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1. Introduction 
The human organism is composed of trillions of living cells. In an adult body, the total 
amount of cells is kept steadily. Progenitor cells undergo mitosis and divide into two 
daughter cells, such that the damaged or worn-out cells that need to be cleared via 
necrosis or programmed cell death can be replaced. The new cells grow, differentiate to 
specialized cells, perform special cellular functions during their life span and undergo 
apoptosis at the end of their “lifetime”. If the proliferation of new cells is out of control 
or the damaged cells carrying modified genotypes escape from apoptosis, cancer could 
emerge [1]. 
In the last few decades, cancer has become more and more serious as a dominate cause 
of death [2]. According to the record of “Cancer Report in Europe”, prostate cancer, 
lung cancer and intestine cancer are the top three kinds of cancer that result in human 
death in men, while breast cancer, intestine cancer and lung cancer are the top three 
cancers in women [3]. 
1.1. Oxidative stress  
Cells in aerobic organisms need energy to survive and to maintain their house-keeping 
functions for the body. In human cells, adenosine triphosphate (ATP) is the most 
important source of energy [4]. During the ATP generation process, the oxidative 
phosphorylation of glucose, reactive species and primarily pro-oxidants are produced, 
and immediately detoxified by the cellular anti-oxidant defence systems. As a result 
of the detoxification, the concentration of reactive species in healthy mammalian cells 
is precisely regulated in a specifically dynamic range to maintain the cell’s various 
functions [5, 6]. 
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In general, cancer cells need more cellular energy supply because they proliferate 
much faster than the healthy cells in organs [1]. In order to survive and adapt to such a 
“tough” microenvironment like hypoxia and nutrient deprivation, cancer cells need to 
maintain their energy supply differently, which usually leads to their suffering from 
oxidative stress (OS) [7]. OS is a phenomenon where the balance between the 
pro-oxidants and the anti-oxidants has been broken, and the pro-oxidants dominate in 
this case [8]. OS usually leads to increased intracellular concentrations of reactive 
species, mostly the reactive oxygen species (ROS), as well as the reactive nitrogen 
species (RNS), the reactive nitrogen oxygen species (RNOS) and free metal ions [5, 
8-10]. In fact, increased ROS levels have been observed in many types of cancer cells 
[5] and OS is now considered as a hallmark in many cancer cells, as shown in Fig 1. 
[5, 7, 8, 11-13]. Interestingly, besides cancers, OS is also involved in many other 
diseases, such as inflammation and arthritis [11]. Increased ROS levers in cancer cells 
can increase glycolysis and promote the pentose phosphate cycle to such extent that 
more biological energy can be provided for the uncontrolled cell growth and cell 
immortalization [6, 14, 15]. 
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Fig 1. Different levels of ROS are found in healthy cells and cancer cells and 
elevated ROS levels are a hallmark of many cancer cells. Because of this fairly 
specific tumour redox microenvironment, exogenous ROS stress increases ROS 
levels in cancer cells over a critical threshold leading to cell death. Alternatively, 
inhibition of antioxidant enzymes, conversion of existing ROS to more aggressive 
ROS and catalytic oxidation of thiol proteins/enzymes can also be employed to 
kill such cancer cells rather selectively. The picture has been adapted from [5]. 
1.1.1. Reactive species  
In chemistry, ROS, RNS and RNOS are considered to be very active substances. The 
reactive species exist in two forms, the free radical form carrying unpaired valence 
electrons (e.g. the hydroxyl radical 
·
OH, the superoxide radical O2
·-
 and the nitric 
oxide 
·
NO), and the non-radical form carrying paired valence electrons like H2O2 and 
peroxynitrite ONOO
-
. Both forms are very highly reactive and tend to oxidize many 
biomolecules they encounter. [8]. 
Biologically, the reactive species have “two faces”. On one hand, an increased 
concentration of reactive species results in damage in and to cells. For example, DNA 
damage (shown in Fig 2) induced by the ROS contributes to tumour formation, which 
is now widely accepted in cancer research. Among all the reactive species, ROS are 
the main triggers of carcinogenesis. On the other hand, the reactive oxidizing species 
can also contribute to cell growth, proliferation or apoptosis in healthy cells [8, 9, 
15-17]. 
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Fig 2. An example reaction of DNA (guanine) damage with the hydroxyl radical 
causing damage. The modified guanine, 8-hydroguanine, is mutagenic and 
carcinogenic, which leads to gene instability and tumour formation. This picture 
has been adapted from [10].  
1.1.2. Anti-oxidant defence systems 
Natural anti-oxidant defence systems detoxify ROS or diminish the harmful effects of 
ROS by cleaning ROS rapidly and keeping ROS concentrations at a low steady level 
to maintain ROS homeostasis in cells. Such antioxidant action can protect cells from 
oxidative damages to lipids, proteins and DNA [8]. 
Natural anti-oxidant defence systems against OS can be separated into two types, 
namely the anti-oxidant enzymatic system and the non-enzymatic system [8]. The 
anti-oxidant enzymatic system is composed of enzymes such as catalase (CAT), 
superoxide dismutase (SOD), glutathione peroxidase (GPx), peroxiredoxin (Prx) and 
a range of other peroxidases. SOD catalyzes the reaction of O2
·-
 to H2O2 and O2 [18, 
19]. After that, H2O2 is decomposed by CAT into H2O and O2 [20]. GPx reduces 
H2O2 to H2O by simultaneously oxidizing glutathione 
(L-γ-glutamyl-L-cysteinylglycine, GSH) to glutathione disulfide (GSSG) [20]. Prx 
catalyzes the same reaction as GPx does, yet primarly by oxidizing thiols of cytosolic 
proteins such as thioredoxin (Trx) [21]. The oxidation of protein-SH (thiol-form, 
P-SH) to either S-glutathiolated proteins (PSSG) or protein disulfide (P-S-S-P) is a 
Introduction 
 
5 
 
trigger for the activation of signal transduction pathways such as the activation or 
arrest of cell cycle. This process is reversible: the oxidized form (disulfide) can be 
reduced to thiol form by disulfide reductases, often in the presence of nicotinamide 
adenine dinucleotide phosphate (NADPH). The reduced thiol groups can therefore be 
recycled in subsequent enzymatic oxidative reactions [8, 9, 14]. The main processes 
are shown in Fig 3. 
 
Fig 3. Schematic representation of the homeostasis of the cellular redox balance 
in cells. As the main initial free radical species, the superoxide radical anion can 
be converted to H2O2 by SOD. The resulting H2O2 can be converted to H2O and 
O2 by Catalase (CAT), or detoxified to H2O by GPx (with concomitant 
consumption of GSH) or Prx (using thiol residues in proteins, P-SH as “reducing 
equivalent”). In the presence of NADPH, the oxidized products (GSSG or 
P-S-S-P) can be reduced by glutathione reductase (GR) and thioredoxin (Trx), 
respectively. The recycled GSH and P-SH can be reused in the next oxidative 
reaction. The picture has been adapted from [5, 12]. 
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In contrast to the enzymatic antioxidant system, the non-enzymatic antioxidant system 
consists of small hydrophilic molecules like ascorbic acid (vitamin C, Fig 4) and 
hydrophobic molecules like tocopherols and tocotrienols (i.e. vitamin E group, Fig 4). 
Biologically, these substances can originate either endogenously (e.g. glutathione, 
GSH, see Fig 4) or exogenously (e.g. ascorbic acid). Actually, the two systems are 
working in a cooperative manner. For example, GSH detoxifies H2O2 to H2O in the 
presence of GPx, as mentioned above. 
 
Fig 4. Schematic overview of a non enzymatic antioxidant system. a) selected 
examples for anti-oxidants. b) Oxidation of GSH to GSSG. The oxidative reaction 
takes place at the thiol moiety of GSH. 
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1.2. Apoptosis 
Apoptosis is a form of programmed cell death which takes place during the 
development and aging of normal cells, by which cells can be “replaced” yet the 
overall cell population of tissues can be maintained without affecting biological 
functions of such tissues [22]. Generally, the apoptotic signaling pathways can be 
classified into intrinsic and extrinsic pathways [23], as shown in Fig 5. Extrinsic 
apoptosis pathways can be triggered by so-called death receptors on the plasma 
membrane, which is usually followed by the activation of caspase 8 and its 
down-stream caspase cascades. Intrinsic apoptosis pathways can be activated by 
cellular stresses and involved proteins such as Bcl-2-associated X protein (Bax), 
which can increase the permeability of the mitochondrial membrane. As a 
consequence, cytochrome c could be released into the cytoplasma. Once in the cytosol, 
cytochrome c can further activate caspase 9 and its down-stream caspase cascades. 
Both the extrinsic and intrinsic pathways ultimately lead to the activation of caspase 3 
in the late stage of such signaling cascades [24]. Tumour cells may escape from 
programmed apoptosis by increasing intracellular anti-apoptotic molecules like B-cell 
lymphoma 2 protein (Bcl-2) or by decreasing pro-apoptotic proteins such as Bax 
protein [25]. Overexpressed Bcl-2 can prevent the increase of mitochondrial 
membrane permeability hence keeping cytochrome c inside the mitochondria [26]. 
Furthermore, Bcl-2 protein can inhibit directly the activation of caspase 9 to stop the 
death signaling cascades [26]. 
ROS can activate intrinsic pathways to “push” the cancer cells to undergo apoptosis. 
For instance, it can increase the permeability of the mitochondrial membrane and lead 
to the loss of mitochondrial membrane potential, which causes the increase of the 
mitochondrial ROS and cytochrome c release into the cytosol. Interestingly, the 
released mitochondrial ROS could act as a “second messenger” to trigger further ROS 
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release in neighbouring mitochondria. Thus, a positive feedback loop forms from 
mitochondrion to mitochondrion to release mitochondrial ROS into the cytosol, which 
often leads to severe injury to the mitochondria. This whole process is called “ROS 
induced ROS release” and is likely to play an important role in apoptosis [27], as is 
shown in Fig 5. 
 
Fig 5. Extrinsic and intrinsic apoptotic pathways. Extrinsic signaling begins with 
the activation of caspase 8 by activation of death receptor. Intrinsic signaling 
begins with modification of mitochondrial functions by the Bax protein or other 
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cellular stress factors. Both pathways lead to the activation of caspase 3 as the 
last step to induce apoptosis. Exogenous ROS triggers mitochondrial ROS release. 
The released mitochondrial ROS then in itself acts as “induced exogenous ROS” 
in the cytoplasm to trigger ROS release in the neighbouring mitochondrion which 
leads to apoptosis. The picture has been adapted from [23, 27]. 
1.3. Endoplasmic reticulum stress  
In eukaryotic cells, the endoplasmic reticulum (ER) represents the key organelle 
responsible for protein synthesis processes such as protein translation, protein folding 
and protein transportation. Interestingly, ROS are also involved in protein folding 
processes [28]. Under OS condition in certain cancer cells, the elevated ROS levels 
can result in corrupted ER function in the form of the accumulation of misfolded 
proteins, which is now called endoplasmic reticulum stress (ER stress) [29]. The most 
important response under ER stress, however, is the unfolded protein response (UPR). 
In healthy mammalian cells, UPR activates signaling pathways such as the increasing 
translation of chaperons involved in the protein folding process in order to 
compensate for the accumulation of misfolded proteins in ER. In this way, ER stress 
can be relieved and the normal cellular functions are recovered so that the cell can 
survive [30]. If UPR fails to compensate the corrupted ER function, ER stress 
signaling pathways will be triggered to activate apoptosis in the last step [31]. As 
shown in Fig 6, three pathways are involved in this kind of signaling: 1) the 
PERK/eIF2α/ATF4 pathway [32], 2) the IRE1α/ XBP1 pathway [33], and 3) the 
ATF6 pathway [34]. Among these three pathways, protein kinase RNA-like 
endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1α (IRE1α) and 
transcription factor 6 (ATF6) will be activated as initial events, respectively. Under 
normal conditions, PERK, IRE1α and ATF6 exist in inactive forms by binding to ER 
stress senor binding immunoglobulin protein (BiP). In the presence of UPR, 
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misfolded proteins competitively bind to BiP to release and hence also to trigger the 
respective activities of PERK, IRE1α and ATF6 [35]. The PERK pathway plays an 
important role in cancer cells, because this signaling pathway is involved in the 
cellular protein synthesis. In order to overcome the moderate to extreme hypoxia 
conditions, which exist in many tumour cells, cancer cells will adapt to the inhibition 
of global protein synthesis. Hence the activation of the PERK signaling pathway in 
cancer cells provides the necessary adaption to the hypoxia condition [32]. Therefore, 
PERK/eIF2α/ATF4-pathways will be discussed in more detail later on. 
 
Fig 6. Schematic representation of the 3 signaling pathways involved in the 
unfolded protein response (UPR). Upon the removal of BiP by binding of 
misfolded protein, PERK, IRE1 or ATF6 are activated as early events in these 3 
pathways, respectively. The activation of PERK, IRE1 or ATF6 induces further 
downstream signaling. The picture has been adapted from [36, 37]. 
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1.3.1. The PERK/eIF2α/ATF4 pathway 
Upon the removal of the inhibitory factor BiP from the complex of BiP and PERK 
under UPR, PERK will be released and hence activated as an early event to its 
downstream signaling pathway via its oligomerization and autophosphorylation [35]. 
Activated PERK inhibits the eukaryotic initiation factor 2α (eIF2α) by 
phosphorylation which is involved in the initiation phase of protein translation. Then 
the whole protein synthesis is turned off except the selective expression of anti-stress 
factors such as activating transcription factor 4 (ATF4) [38]. ATF4 is a transcription 
factor in turn regulating the expression of various pro-survival genes involved in the 
oxidative stress response, amino acid synthesis and differentiation. Interestingly, 
under prolonged ER-stress, ATF4 also upregulates the expression of pro-apoptosis 
proteins like C/EBP homologous protein (CHOP) [39]. It still remains elusive, 
however, how exactly CHOP activates apoptotic signaling [40]. It is already known 
that CHOP interacts with the Bcl-2 protein family to activate the intrinsic apoptotic 
signaling [41]. Overexpressed CHOP may, for instance, result in a decrease in Bcl-2 
protein and could trigger the translocation of Bax protein from the cytosol to the 
mitochondria in order to transmit the death signal. Hence, both CHOP-knockout 
(CHOP
-/-
) mice and Bax-knockout (Bax
-/-
) mice are resistant to the apoptotic ER 
stress responses [41-43]. The entire signaling of PERK/eIF2α/ATF4 pathway is 
summarized in Fig 7. 
Furthermore, the activation of PERK triggers not only the phosphorylation of eIF2α, 
but also the phosphorylation of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2 
or Nrf2) [37], as shown in Fig 7. Nrf2 is involved in antioxidant response pathways, 
which are described as "the primary cellular defence against the cytotoxic effects of 
oxidative stress" [44-46]. These pathways contribute to the survival of the cells under 
OS. Under normal conditions, Nrf2 exists in an inactive form by binding to kelch 
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like-ECH-associated protein 1 (Keap1) and cullin 3 proteins. Activated PERK 
phosphorylates Nrf2, which leads to its dissociation from the protein complex of Keap 
1 and cullin 3. Activated Nrf2 upregulates the expression of antioxidant enzymes like 
heme oxygenase 1 (HO-1) to detoxify the cytotoxic effects of ROS [37, 47]. 
 
Fig 7. Schematic representation of PERK mediated signaling pathways. Under 
ER stress, unfolded proteins bind to BiP competitively, which releases PERK 
from BiP. Then, PERK is activated by its oligomerization and 
autophosphorylation. Activated PERK phosphorylates Nrf2 as well as eIF2α. 
Phosphorylation of Nrf2 leads to its dissociation from Keap1. The activated Nrf2 
proteins translocate into cell nucleus to promote the transcription of redox 
response genes like HO-1. Phosphorylation of eIF2α attenuates the translation of 
general proteins. Interestingly, phosphorylated eIF2α selectively promotes the 
translation of ATF4. ATF4 targets both anti-apoptotic and pro-apoptotic genes. If 
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the ER stress exceeds its critical threshold, ATF4 will contribute to the 
transcription of the CHOP proteins. CHOP inhibits the transcription and hence 
activity of Bcl-2 proteins and hence triggers pro-apoptotic signaling cascades. 
The picture has been adapted from [36, 37, 40, 47]. 
Interestingly, cancer cells can survive PERK/eIF2α/ATF4 pathway-induced apoptosis. 
Therefore, one rationale in the development of anti-cancer durgs involves an increase 
of ER stress in cancer cells which subsequently activates the apoptotic pathway [36, 
48]. 
1.4. Cell cycle 
Cells proliferate via cell cycle. This process can be divided into three subphases: 
quiescent, interphase and cell division. Quiescent (G0) is a resting phase. Cells in the 
G0 phase can be activated by cytokines to enter the interphase that in itself contains 3 
subphases, Gap 1 (G1), the synthesis period (S phase) and Gap 2 (G2). In G1, proteins 
are synthesized and the amount of cellular organelles is increased. The S phase starts 
with the synthesis of DNA and stops when all of the chromosomes have been 
duplicated. The G2 phase is a gap phase between S phase and the cell division phase. 
After further preparation in the G2 subphase, the progenitor cell finally undergoes 
mitosis, e.g. the pro-, prometa-, meta-, ana-, and telophase, and divides into two 
daughter cells [49]. 
Three key events are involved in the whole cell division process to ensure a high 
integrity of DNA in the two daughter cells: DNA replication in S phase, spindle 
formation and segregation of chromosomes during cell division. A defect in each of 
those three events could lead to genetic instability and tumour formation [50, 51].  
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The spindle apparatus is based on the fundamental machinery of microtubules and 
ensures the correct segregation of chromosomes between the two daughter cells 
during cell division. The highly dynamic cytoskeletal structures of microtubules are 
crucial for cell division in the prophase, prometaphase, and metaphase during mitosis. 
Tubulins are the basic components of microtubules and exist in 6 forms, of which α- 
and β-tubulin are the most common members of the tubulin protein family. 
Anti-cancer drugs like paclitaxel interfere with the microtubule dynamics by binding 
to the tubulins and therefore exhibit powerful anti-mitotic properties. These drugs lead 
to cell cycle arrest and apoptosis, and even to changes of microtubule mass under 
applied high doses [52-54]. 
1.5. Red blood cells 
Before all the molecules that contain selenium and tellurium designed (described 
below in chemical considerations) can take effects inside the cell cytosol, they must 
cross the cell membrane before they can interact with their target proteins. Hence 
these compounds need specific ways to enter the cells, but this kind of facilitation 
should keep the integrity of the cell membrane. In contrast, certain compounds may 
also disrupt the membrane and hence the cell membrane can be considered as their 
prime target. Therefore, the interaction of the compounds with the cell membrane was 
investigated prior to all the anti-cancer experiments.  
Mature red blood cells (RBCs) in mammals lack a cellular nucleus and the organelles 
such as mitochondria and do not possess complex signaling pathways. Therefore, 
RBCs are considered as an ideal model for investigating the interactions of chemical 
compounds with the cell membrane and the embedded proteins [55].  
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1.5.1. Cell membrane of red blood cells 
The cell membrane of RBCs with a typical thickness of 7.5 nm is composed of lipids 
(41%), proteins (52%) and carbohydrates (7%) [56]. Lipids constitute the 
infrastructure of the cell membrane. They can be classified into three types: 
phospholipids (62.7%), neutral lipids (25.2%) and glyco-sphingophospholipids (ca. 
12%) [57]. The most common phospholipids of human RBCs are sphingomyeline 
(Sph 26%), phosphatidylcholine (PC, 30%), phosphatidylethanolamine (PE, 27%) and 
phosphatidylserine (PS, 13%) [58, 59]. Phospholipids are asymmetrically distributed 
in the plasma membrane of the RBCs due to the presence of lipid transporters such as 
flippase, floppase and scramblase: normally, Sph and PC are located in the outer 
leaflet of the plasma membrane predominantly, while PE and PS are found in the 
inner leaflet of human RBCs. [60]. 
1.5.2. Performance of the interaction with cell membrane of red blood cells 
The interaction of the compounds tested with the cell membrane or with the 
embedded proteins on the cell membrane can be presented in two forms: haemolysis 
and eryptosis. Due to the fact that the newly designed compounds are amphiphilic as 
surfactants, the interaction of surfactants with the cell membrane of RBCs will be 
discussed in detail. 
The surfactants such as sodium dodecyl sulfate (SDS), which interact strongly with 
the cell membrane of RBCs, can cause haemolysis, while others such as 
benzethonium, which interact “softly” with the cell membrane, cause RBC to undergo 
eryptosis [61]. Eryptosis is the specific form of apoptosis of worn-out RBCs which is 
mediated by phosphatidylserine (PS) exposure from the inner to the outer leaflet of 
the membrane [62]. PS on the outside of the cell membrane can be detected by 
Introduction 
 
16 
 
macrophages. As a result, the worn out RBCs will be degraded by macrophages via 
phagocytosis. Therefore, PS exposure can be described as a biomarker for eryptosis. 
[63]. Elevated intracellular Ca
2+
 level in RBCs activate the scramblase and inhibit the 
flippase. These two processes will result in PS exposure on the cell surface [63, 64]. 
 
Fig 8. Schematic representation of the different lipid transporters. 
Phosphatidylserine (PS) and phosphatidylethanolamine (PE) are translocated 
by flippase from the outer to the inner leaflet of the plasma membrane with ATP 
consumption. Floppase transports PC in the opposite direction. Scramblase 
exchanges PC with PS in an ATP-independent manner. The picture has been 
adapted from [60]. 
1.6. Chemical considerations of the “chemistry” of redox modulation  
It is already known that OS is present in many kinds of cancer cells due to hypoxia 
and energy deficiency. In such cases, the ROS levels have almost reached the critical 
redox threshold to trigger apoptosis in such cancer cells. The process does not take 
place in healthy cells. In the last few years, the effects of ROS in cancer cells and 
their modulation with small molecule compounds have drawn more and more 
attention. These compounds effectively work on the cancer cells and selectively 
inhibit the growth of these cells [65]. Such agents may, for instance, induce ROS 
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production in cancer cells to overwhelm the critical redox threshold, which would 
subsequently trigger the apoptosis signaling cascades. In contrast, although the ROS 
level could also be raised to a higher level with these compounds in healthy cells, 
these cells will not undergo apoptosis, because their energy metabolism and natural 
defence systems are still kept intact, i.e. these cells are “naturally” far away from the 
critical redox threshold. Based on the specific roles of ROS in cancer cells, there are 
three general strategies to design and develop new anti-cancer drugs as redox 
modulators [13], as is shown in Fig 9.: 
A. Compounds are designed to raise the ROS level. 
B. Compounds are designed to inhibit the antioxidant systems.  
C. Compounds are designed to act as redox catalysts [13]. 
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Fig 9. Overview of the rational design for different types of redox modulators. a) 
Doxorubicin is shown as an example of a drug used for the generation of ROS, 
2-methoxyestradiol represents an example of a drug used for inhibition of 
antioxidant systems and 4,4'-tellurodiphenol is an example of a drug which cause 
the catalytic oxidation of cellular thiols with the presence of ROS. b) In healthy 
cells, the redox balance is kept intact. In contrast, ROS generating drugs elevate 
the ROS level in the cells but still keep below the critical redox threshold. Due to 
the intact natural defence system in non cancerous cells, the effect of the 
·
OH 
radical or minor oxidation of proteins can be compensated, therefore, the healthy 
cells can survive (A). In cancer cells, the elevated ROS level “naturally” reaches 
almost the threshold to trigger apoptosis. ROS generating drugs like doxorubicin 
or drugs that inhibit antioxidant systems, like SOD-inhibitor 2-methoxyestradiol, 
raise the ROS levels over this threshold. In this case, the cancer cells undergo 
apoptosis (B and C). Some SOD-mimics convert the existing ROS to more 
aggressive and toxic radicals (
·
OH) (C). GPx-mimics like 4,4'-tellurodiphenol 
catalyze the oxidation of thiol groups (in proteins and enzymes) by H2O2, which 
leads to possible oxidation of proteins (and/or GSH) to induce the apoptosis in 
cancer cells (E). The picture has been adapted from [13]. 
Based on the fact that the redox modulators have shown effective anti-cancer 
properties in many cell-based assays, this thesis is focused on the design and the 
development of selenium (Se)- and tellurium (Te)-containing compounds as 
promising anti-cancer drugs. It should be noted that such selenium and tellurium 
compounds are believed to work as catalysts rather than simple antioxidants.  
Se and Te belong to the chalcogens in Group 16 of the Periodic Table, which is also 
known as the “oxygen family”. Chemically, the oxidation states of Se and Te vary 
from -2 to +6.  
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Se is an essential trace element in the human body. It forms a component of proteins, 
for example, the glutathione peroxidase enzymes which are maintaining a low level of 
H2O2 in the cell. Lack of Se can lead to general fatigue, mental fatigue, 
hypothyroidism and even to more serious ailments such as reproductive disorders and 
miscarriage. Synthetic organo-selenide derivatives (with oxidation state -2) have been 
considered as antioxidants for a long time [66], other physiological activities have 
also been emerging. Ebselen (2-Phenyl-1,2-benzoselenazol-3-one), for instance, can 
induce apoptosis in various cancer cells [67-71]. The pro-apoptotic effect of ebselen 
has been investigated in multiple myeloma and human hepatoma cancer cells and 
seems to be related to enhance ROS levels in both cancer cell lines. N-acetyl cysteine, 
which is a precursor of intracellular GSH synthesis, can alleviate ebselen-induced 
apoptosis. These results suggested that ebselen can accelerate the oxidation of thiol 
moieties by H2O2, e.g. in GSH [67, 71]. The underlying mechanisms explaining the 
action of ebselen are depicted in Fig 10 [72]. The thiol moiety in GSH is not the only 
SH moiety that is involved in this scenario, but also the cysteine residues in proteins 
(P-SH). Once thiol groups in proteins have become oxidized to P-S-S-P, the structures 
and functional activities of these proteins will be altered, ultimately trigging various 
signaling pathways. This process may also induce apoptosis [13, 65, 73, 74]. 
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Fig 10. The redox mechanisms of GPx-mimics using ebselen as an example. 
There are three possible catalytic redox cycles. Cycle A: Ebselen could be 
oxidized by H2O2 to the selenoxide derivative a. The selenoxide a could be 
converted to the thiolseleninate b by reduction with one thiol group, then, the 
latter could be reduced again by anther thiol group to seleninic acid c. Ebselen 
may be recycled via elimination of H2O. Cycle B: Ebselen could be reduced 
directly by a thiol group to form selenyl sulfide d. Subsequently, compound d is 
able to react with another thiol group to form selenol e, which may be reoxidized 
by H2O2. Cycle C: The selenyl sulfide d could also be reduced by a thiol group 
leading to the diselenide f, which may form ebselen again after oxidation by H2O2 
and intramolecular rearrangement. This picture has been adapted from [72]. 
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In contrast to Se-compounds, Te-compounds have long and widely been believed to 
be biologically “useless” and even toxic for humans. Recently, however, several 
organic tellurium compounds have been reported as promising anti-cancer drugs [13, 
65, 74-76]. A widely accepted mechanism proposes that those Te compounds may 
show similar biological activities as their analogues Se compounds, because, 
chemically, Te is mostly relative of Se [75]. The activities of these Te-compounds, 
however, still remain elusive. Some organic phenyl telluride (oxidation state -2) 
derivates have been reported to generate ROS, which causes cancer cells to undergo 
apoptosis by halting cell proliferation or by inducing DNA damage in HL-60 cells 
(chemical structures of such compounds as shown in Fig 11. a)) [77]. Furthermore, 
inorganic Te-compounds also seem to contribute to the modulation of the intracellular 
redox balance, such as potassium tellurite (K2TeO3, oxidation state of tellurium +4) 
[78]. 
Organic quinone-telluride derivates (oxidation state of tellurium -2) designed by 
Jacob and co-workers, such as 2,3-bis(phenyltellanyl)naphthoquinone and 
2-(phenyltellanyl)-3-methylnaphthoquinone, are able to elevate intracellular ROS 
levels, induce apoptosis, signaling and disturb tubulin and actin structures in PtK2 
potoroo and KB-3-1 cells [74, 79]. Some of these compounds, such as 
2,3-bis(phenyltellanyl)naphthoquinone, also show very selective anti-proliferating 
effects against HT29 and CT26 human colon cancer cells but not against normal 
fibroblast cells like NIH-3T3. Similar effects have been observed in human chronic 
lymphocytic leukemia (CLL) cells [75]. The 2,3-bis(phenyltellanyl)naphthoquinone 
considerably reduced the viability of CLL B-cells isolated from patient blood, while 
healthy B-cells from the same patient were much less affected (structures shown in 
Fig 11 b)) [74]. It is very difficult, however, to synthesize these compounds. 
Furthermore, many organic tellurium-contaminating substances are insoluble in water 
or decompose easily. In fact, in order to increase stability, aryl- and allyl-groups need 
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to “flank” the reactive atom, which in turn causes issues related to solubility. 
Therefore, new and simple organic selenium and tellurium containing compounds 
have been designed and synthesized carrying these elements. These compounds have 
been designed to improve their water solubility, cell membrane permeability and to 
show an improved biological activity. 
 
Fig 11. Organotellurium compounds evaluated previously for redox-modulating 
biological activity. a) Tested with HL-60 cells based assays. b) Organic 
quinone-telluride derivates. This picture has been adapted from [74, 79]. 
The compounds designed must cross the cell membrane before they can modulate the 
redox cycle in the cell to perform the biological activities. Therefore, the structure of 
cell membrane was extensively considered. The mammalian cell membrane consists 
of a phospholipid bilayer with embedded proteins [80]. Biophysically, a phospholipid 
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is a surfactant that is composed of one hydrophilic head group, and the lipophilic tail 
that contributes to the solubility in oil phase. Therefore, surfactants dissolve both in 
H2O and in oil. Due to the high similarities with the components of the cell membrane, 
synthetic surfactants can interact with the cell membrane and even penetrate it [81]. 
To achieve water solubility and penetration of the cell membrane in one go, 
surfactant-like molecules with both hydrophilic and hydrophobic properties can be 
considered.  
In the early 1980s, it has been reported already that some organic tellurium-containing 
derivatives of fatty acids can be taken up by cells and then trapped specifically in the 
myocardium. Therefore, these fatty acids could be used as a biomarker of cardiac 
diseases [82]. Based on the structures of these chalcogen containing fatty acids, a 
specific design strategy has been developed. The rationale is: 1. Se and Te (-2) are 
supposed to provide biological effects of modulating ROS levels in cancer cells; 2. 
The Alkyl chain, Se (or Te) and phenyl groups are arranged in tandem, such that the 
Se (or Te) atom could be stabilized by the phenyl group during the catalytic cycle in 
the cells; 3. Due to the replacement of the alkyl group by the phenyl group on one side 
of Se (or Te), the absorption by cells could be affected, hence the length of the alkyl 
group on the other side is varied to investigate the correlation between amphiphilicity 
(in respect of the critical micelle concentration (CMC)) and their biological activities 
to select the best compound for biological tests on cancer cells. To increase solubility 
in aqueous media, the sulfuric acid group was used as head group for these new 
amphiphilic compounds. Because sulfuric acid (a strong acid) can dissociate fully in 
water, the sulfuric acid group provides excellent hydrophilicity and is superiors to, for 
instance, the carboxylic acid group. Thus, ten compounds as shown in Fig 12 have 
been designed, synthesized, purified and characterized chemically. The results of 
subsequent biological tests indicated that these sulfates can readily penetrate the cell 
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membrane, induce ROS, trigger ER stress and finally induce apoptosis in HCT 116 
cells. 
Fig 12. The design of the selenium- and tellurium-containing compounds based 
on the idea of water soluble and cell membrane penetrable at the same time. The 
part of Ph-Se- Alkyl chain fuctions as hydrophobic tail and the SO3Na as 
hydrophilic head. See text for further details. The picture has been adapted from 
[83]. 
Interestingly, the cellular redox state can be modulated not only by selenide 
compounds, but also by other seleno-compounds such as seleninic acid derivates [84]. 
Chemically, seleninic acid (+2) only functions as a pro-oxidant. Thus, seleninic acid 
can be directly reduced by thiol moieties within a few seconds [85, 86]. The reduced 
selenide can subsequently participate in the catalytical redox cycle as discussed above. 
Unfortunately, due to their chemical property of being an acid, chemically simple 
seleninic acid derivates cannot penetrate the cell membrane. Therefore, the usage of 
seleninic acid as biological redox catalysts is prevented. In order to solve this problem 
and turn this high hydrophilicity into an advantage, the seleninic acid has been used as 
a suitable head group of amphiphilic molecules. This method has shown considerable 
success. 
Compound X n
DP 31 Se 8
DP 32 Se 9
DP 33 Se 10
DP 34 Se 11
DP 35 Se 12
DP 41 Te 8
DP 42 Te 9
DP 43 Te 10
DP 44 Te 11
DP 45 Te 12
X O
SO3Nan
HydrophilicheadHydrophobic tail
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Fig 13. The chemisty of seleninic acid derivates. The seleninic acid can be 
reduced by two thiol groups (HS-P) leading to selenenic acid (R-Se-OH). Further, 
the selenenic acid can react with another two thiol groups to form selenodisulfide 
(R-Se-S-R) first, and then a selenol(R-SeH), which enters into the redox catalytic 
cycle. This picture has been adapted from [87]. 
Based on similar rationales in designing selenide surfactants, new series of seleninic 
acid derivates has been designed to the deliver seleninic acid moiety into cells, as 
shown in Fig 14. In this case, seleninic acid is used directly as the head group. This 
head combines two functions: hydrophilicity and biological activity. 
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Fig 14. The design of seleninic acid derivates based on the idea of a surfactant. 
The seleninic acid acts both as hydrophilic head and carrier of selenium specific 
biological activity. See the text for further details. This picture has been adapted 
from [88]. 
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2. Result and Discussion 
In this chapter, three publications are described by Diplom Apotheker Peng Du as first 
author. The synthesis of the new selenium and tellurium containing surfactants as well 
as the screening of their activities with nematodes, RBCs, RAW 264.7, HCT116 and 
ARPE-19 cells are shown in the first publication. The signaling transduction to induce 
apoptosis with the tellurium compound DP41 in HCT116 cells is described in the 
second publication. The synthesis of seleninic acid containing surfactants and their 
activities against RBCs and S. cervisiae are summarized in the third publication. 
2.1. Pulication 1 
Synthesis of amphiphilic, chalcogen-based redox modulators with in vitro 
cytotoxic activity against cancer cells, macrophages and microbes 
Peng Du, Uma M. Viswanathan, Khairan Khairan, Tomislav Buric, Nathaniel E. B. Saidu, 
Zhanjie Xu, Benjamin Hanf, Inga Bazukyan, Armen Trchounian, Frank Hannemann, Ingolf 
Bernhardt, Torsten Burkholz, Britta Diesel, Alexandra K. Kiemer, Karl-Herbert Schäfer, 
Mathias Montenarh, Gilbert Kirsch and Claus Jacob 
This manuscript was published as an article in the following Journal: 
Medicinal Chemistry Communications, 2014, 5, 25-31 
DOI: 10.1039/C3MD00204G 
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2.1.1. Abstract 
Several amphiphilic, chalcogen-based redox modulators have been synthesized which 
exhibit a widespread, yet in some instances also selective, biological activity which is 
most likely based on their ability to modulate the intracellular redox balance and to 
interact with cellular membranes and specific proteins. 
2.1.2. Introduction 
The last decade has witnessed a growing interest in the development of redox 
modulating agents, which are able to effectively, yet also selectively, attack cells with 
a disturbed redox balance, such as diverse cancer cells, macrophages and 
sclerodermic fibroblasts.
1–5
 A similar strategy has also been employed to kill various 
microorganisms, which are vulnerable because of a weak antioxidant defence.
1,6–8
 In 
many cases, catalytic selenium and tellurium agents have been at the forefront of 
these developments, since these compounds exploit the efficiency and selectivity of a 
chemical catalyst for its intracellular substrate(s) to generate pronounced cytotoxic 
events in specific cells.
4–6,9,10
 Such compounds are, for instance, able to induce 
apoptosis in leukemic B-cells while healthy B-cells of the same patient remain largely 
unaffected.
2,11
  
Unfortunately, many of the most interesting organoselenium and tellurium agents 
available to date are only poorly soluble in aqueous media and often unstable – and 
hence possess a comparably poor bioavailability and drug profile, even in cell culture. 
While attempting to circumvent some of the problems associated with such 
unfavourable physico-chemical properties, the idea of amphiphilic redox modulators 
has emerged, as detergent-like properties may, at least in theory, bestow such 
molecules with certain additional, quite beneficial aspects. Firstly, such amphiphilic 
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compounds should be fairly soluble in aqueous media. Secondly, amphiphilic 
structures should cross cell membranes and hence enter cells more easily when 
compared to more hydrophilic or lipophilic agents. Thirdly, amphiphilic agents should 
be able to interact strongly with membranes and (hydrophobic parts of) proteins. And 
finally, such agents may cluster together at certain cellular sites (e.g. at membranes, in 
hydrophobic pockets) and hence may act synergistically. 
Surprisingly, only few suitable amphiphilic redox-modulating agents have been 
reported in the literature so far, and most of these substances have not been studied 
comprehensively in cell culture.
12,13
 Recently, some relevant chalcogen compounds 
have emerged in this context in the literature, confirming that the synthesis of such 
structures is realistic.
13
 
2.1.3. Result and discussion 
We have therefore decided to synthesize a series of amphiphilic selenium and 
tellurium compounds with an anionic head group and hydrocarbon ‘tails’ of different 
tail lengths in order to explore the various aspects – and possible benefits – of such 
agents in the context of biological activity, selectivity and mode(s) of action. The 
compounds ultimately selected and subsequently synthesized as part of this study are 
shown in Fig. 1. The design of these compounds combines aspects of previously 
studied selenium and tellurium compounds (e.g. aryl substituents for enhanced 
stability) with typical features of an amphiphilic agent.
13
 As for the synthesis of such 
compounds, once the most promising synthetic avenue was selected (see Fig. 1), the 
preparation of these molecules has been fairly straightforward (see the ESI†). In many 
instances, good yields (up to 63%) were possible even without further optimization. 
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Fig 1. Chemical structures of compounds selected for this study. The most 
successful synthetic route is provided (see text and ESI for details†) 
Once synthesized and chemically characterized, the two most interesting 
physico-chemical properties associated with these compounds from a biological 
perspective (i.e. the amphiphilic and redox properties) have been confirmed using 
surface tension measurements and cyclic voltammetry. The results, illustrated 
exemplarily for DP33 and DP43 in Fig. 2 and summarized in Table 1, confirm that the 
compounds selected indeed possess amphiphilic properties, with Critical Micelle 
Concentrations (CMCs) in water in the low millimolar range (Fig. 2a). As expected, 
the CMC values of these compounds generally decrease with increasing hydrocarbon 
chain length, and compounds DP35 and DP45, respectively, show the lowest CMC 
values of the selenium and tellurium compounds studied. Under these conditions, the 
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selenium-containing compound DP35 has a CMC of 0.7 mM and the 
tellurium-containing compound DP45 of just 0.3 mM, which is comparable to the 
CMC of sodium dodecylsulfate (SDS) under these conditions (Table 1). The latter is 
used here as a benchmark anionic surfactant and has a CMC of 0.9 mM under the 
experimental conditions used. Interestingly, there is no major difference in CMC 
values between the selenium and tellurium analogues. 
 
Fig 2. Biologically relevant physico-chemical properties associated with the 
amphiphilic compounds investigated: (a) representative surface tension 
measurements of ‘average tail length’ (n = 10) selenium compound DP33 and 
tellurium compound DP43 in order to determine the CMC values of these compounds 
and to compare them to the benchmark surfactant SDS. (b) Cyclic voltammograms of 
the same compounds to demonstrate redox activity and to determine Epa values. 
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Compound  X  n  Yield 
(%)  
CMC 
(mM)  
Epa 
(mV)  
Lysis of 
RBCs (%) 
at 100 µM  
IC50 (µM) 
against 
HCT116  
IC50 (µM) 
against 
RAW   
SDS  -  -  -  0.9 -  9.51 ± 1.31  ˃ 100  ˃ 100  
31 Se  8 64 2.6 472.3 1.24 ± 0.18  ˃ 100  ˃ 100  
32 Se  9 73 2.5 783.8 2.73 ± 0.63  ˃ 100  ˃ 100  
33 Se  10 77 1.2 819.4 7.94 ± 1.81  ˃ 100  ˃ 100  
34 Se  11 67 1.1 822.2 63.41 ± 4.02  ˃ 100  ˃ 100  
35 Se  12 81 0.7 826.5 66.80 ± 2.55  ˃ 100  ˃ 100  
41 Te  8 63 5 306.1 3.09 ± 0.07  5.99 ± 1.16  3.95 ± 1.16 
42 Te  9 80 4.8 363.1 20.44 ± 0.90  4.99 ± 1.46  4.67 ± 1.01 
43 Te  10 77 0.9 374.5 45.35 ± 1.35  7.47 ± 0.74  5.32 ± 1.20  
44 Te  11 81 0.5 385.9 53.35 ± 3.35  9.73 ± 0.34  7.84 ± 1.22 
45 Te  12 82 0.3 385.9 67.61 ± 2.04  19.84 ± 1.26  4.96 ± 1.41  
Table 1. Overview of the most relevant physico-chemical parameters and biological 
activities associated with the compounds developed and evaluated as part of this 
study. See text and ESI for further details† (Epa values vs. SSE)  
At the same time, these compounds are redox active and exhibit an electrochemical 
behaviour more or less typical of mono-selenides and tellurides (Fig. 2b). Here, the 
oxidation potentials Epa are typically in the range of +472 to +827 mV vs. the standard 
silver/silver chloride electrode (SSE) for the selenides and +306 to +386 mV vs. SSE 
for the tellurides. In contrast to the CMC values, the Epa values therefore do differ 
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significantly between the selenium and tellurium analogues, in line with previous 
reports pointing towards generally lower Epa values for tellurium compounds 
compared to their selenium analogues. Interestingly, the Epa values within the 
respective selenium and tellurium series do seem to increase with increasing 
hydrocarbon ‘tail’ length; yet these increases are in the range of a couple of tens of 
millivolts only and hence minor in comparison. 
While it is unlikely that such amphiphilic agents form micelles under physiological 
conditions – the concentrations generally employed in cell culture are too low for 
micellation and the complexity of the biological ‘buffer’ also interferes with micelle 
formation – they should still be able to interact rather strongly with – hydrophobic 
parts of – biomolecules surrounding the cell or being present therein. Within this 
context, and in analogy to the action of SDS, interactions with cellular membranes 
and with proteins are of particular interest.
14
 We have therefore briefly explored the 
potential interactions of some of our compounds with the membrane of red blood cells 
(RBCs) and/or whole RBCs with a representative protein, i.e. haemoglobin (Hb) (see 
also the ESI†). 
RBCs were chosen to study compound–membrane interactions as they represent intact 
cells rather than just liposomes. RBCs therefore enable the study of direct effects of 
compounds on the cell membrane, yet do not possess the kind of signaling usually 
associated with dividing cells.
14
 We know, for instance, that redox modulators can 
trigger secondary, indirect responses in dividing cells, hence complicating 
investigations (see also below).
9,15,16
 Fig. 3 shows the pronounced effect of the 
selenium and tellurium containing agents on the integrity of the RBCs. This effect is 
concentration dependent (see Fig. S1 in the ESI†). Rather modest concentrations of 
compounds such as DP35, DP44 and DP45 cause significant lysis of the cell 
membrane, as determined by the haemoglobin release assay. Compound DP45 is the 
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most ‘active’ in this assay, with 67.6% lysis at 100 μM of the compound tested. This 
compound has also the lowest CMC value (around 300 μM), indicating that the 
activity on the RBC cell membrane is apparently dominated by the amphiphilic 
character of the compounds and is less dependent on the nature of the chalcogen 
involved. Indeed, there is a dramatic increase in lysis with increasing hydrocarbon 
chain length in the selenium as well as tellurium series, from a couple of percents in 
the case of short tails (DP31, DP41) to almost 70% in the case of the longest tails 
(DP35, DP45). There is only a slight increase in lysis when switching from selenium 
to tellurium (66.8% lysis in the case of DP35 and 67.6% in the case of DP45). 
Therefore the impact of compounds such as DP34, DP35, DP44 and DP45 on the cell 
membrane is driven primarily by the amphiphilic character of these agents, and is 
possibly slightly enhanced by the presence of tellurium. Although speculative at this 
time, one may envisage that the primary interaction of these compounds is indeed 
with the phospholipid bilayer directly, while a smaller, secondary, chalcogen-driven 
effect is perhaps due to yet to be specified interactions with – probably cysteine 
containing – membrane proteins. A similar behaviour apparently dominated by 
amphiphilicity rather than redox activity has also been found in the case of nematodes, 
whose cuticula or epidermis may be the target of such compounds (see below). 
 
Fig 3. Interactions of amphiphilic compounds with possible biochemical target 
molecules. Membrane interactions were recorded with subsequent lysis of RBCs 
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(at a compound concentration of 100 μM). The chain lengths refer to n, the 
number of carbon atoms in the hydrophobic tail, as defined in Fig. 1. Lysis of 
RBCs increases with increasing tail length from n = 8 (DP31 and DP41) to n = 
12 (DP35 and DP45). Data are presented as mean ± SD, and one-way ANOVA 
test (Dunnett) is used: p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***). 
In the next step, we have turned our attention to possible (non-covalent) interactions 
with proteins. Here, Hb has been used as the initial choice as this protein occurs 
commonly in RBCs, exhibits distinct signals in CD and, as a metalloprotein, also 
accounts for possible chalcogen–metal interactions (the iron–sulfur cluster containing 
protein Adx has been used as a further control). Indeed, the studies employing circular 
dichroism (CD) in order to determine possible interactions of the amphiphilic agents 
with Hb indicate rather pronounced effects of these compounds on the secondary 
structure of such proteins. At 50 μM concentrations, most of the compounds studied 
showed some impact on the Hb structure, which was comparable to that of SDS at the 
same concentration. The underlying interaction(s) were not particularly specific and 
seemed to be dominated by the amphiphilic character of the molecules (see Fig. S2 in 
the ESI†). SDS and DP31 had pronounced effects on the structure of Hb, while the 
impact of DP41 was less apparent. Interactions of such compounds with the protein 
structure could also be observed in the case of the reference protein Adx, where DP41 
was slightly more potent than DP31 (see the ESI†). 
Encouraged by these results, which clearly support the notion of possible multiple 
interactions of such compounds with various types of biomolecules, we have turned 
our attention towards potential biological targets. In the first part of the evaluation of 
biological activity, two different epithelial human cell lines have been chosen: human 
colon cancer cells (HCT116 cells, ATCC® CCL-247™) represent a well established 
cancer cell model, while human retinal pigment epithelia cells (ARPE-19, ATCC® 
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CRL-2302™) provide a suitable and often acceptable control as they exhibit many 
features of non-cancerous, primary cells, yet do not result in the various practical and 
ethical issues associated with using primary human colon cells obtained, for instance, 
from biopsies. ARPE-19 cells are particularly suited as control cells when the activity 
of redox modulating agents is investigated, as such epithelial cells are fairly resilient 
towards oxidative stress.
15
 Hence screening compounds against HCT116 and 
ARPE-19 cells in tandem often allows a first but certainly preliminary glance at 
cytotoxicity against human cells and also a comparison of a cancer cell line with 
‘normal’ cells.2,15–17 
Fig. 4 shows the results obtained for a set of amphiphilic compounds against HCT116 
and ARPE-19 cells (for IC50 values see Table 1). While the selenium-containing 
compounds and SDS were more or less inactive against HCT116 cells at the 
concentrations used, all of the tellurium containing compounds showed considerable 
cytotoxic activity against these cancer cells with IC50 values in the range of 5 to 20 
μM. Interestingly, a small but consistent and statistically significant, ultimately 
around 3–4-fold, increase in IC50 values was observed when the hydrocarbon tail 
length was increased, from 6.0 μM in the case of DP41 to 19.8 μM in the case of 
DP45. In line with the notable absence of any observable cytotoxicity associated with 
the selenium compounds (DP31 to DP35) up to a concentration of 100 μM, this trend 
in IC50 values obviously counts against (purely) amphiphilic (inter-)actions of such 
compounds. 
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Fig 4. Selective cytotoxicity of tellurium compound DP41. Panel (a): cytotoxicity 
of DP41 in HCT116 cells compared to the less cytotoxic selenium analogue 
DP31 and SDS. Panel (b): cytotoxicity of DP41 in HCT116 cells compared to 
ARPE-19 cells. Data are presented as mean ± SD, t-test is used, p < 0.05 (*), p < 
0.01 (**) or p < 0.001 (***). Panel (c): cytotoxicity of DP41 in RAW 264.7 cells 
compared to the less cytotoxic selenium analogue DP31 and SDS. 
Here, one must bear in mind, of course, that the IC50 values (below or around 20 μM) 
are considerably lower than the concentrations employed for lysis of RBCs (100 μM), 
which in turn are lower than the CMCs (300 μM in the case of DP45). It is therefore 
likely that most of the most dramatic amphiphilic effects of such compounds only 
come to bear at concentrations which are 10-fold or even higher than the ones 
required to kill a human cell. In the case of the most cytotoxic compound DP42, the 
b)
c)
a)
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IC50 value in HCT116 cells is around 1000 times lower than the CMC of this 
compound. 
In fact, while longer chain lengths may promote interactions with cell membranes (as 
seen in the case of RBCs), they may also prevent compounds from ultimately crossing 
such membranes, i.e. from leaving the membrane again and entering the cytosol. In 
the case of one of the most active compounds, DP41, we have therefore used 
Energy-dispersive X-ray spectroscopy (EDX) to confirm the presence of tellurium 
inside (washed) HCT116 cells (see Fig. S3 in the ESI†). While it is not possible to 
confirm the exact location and chemical state of tellurium inside these cells using this 
method, EDX nonetheless confirms that the compound has crossed the cell membrane 
and indeed is ultimately present inside the cell. 
Amazingly, the IC50 values of some of these tellurium agents were consistently lower 
in HCT116 cells when compared to the IC50 values of the same compounds in 
ARPE-19 cells (the latter were usually around 50 μM), pointing towards a high and, 
in this case, also selective activity in the HCT116 cell line. While it is premature to 
speculate why such tellurium compounds may be particularly active in HCT116 cells 
– and not to the same extent in ARPE-19 cells, and why the selenium analogues are 
not active in HCT116 cells, these findings are in excellent agreement with previous 
results obtained for organotellurium compounds in such cell lines.
10
 They also 
confirm once more the significantly higher cytotoxicity associated with tellurium 
compounds when compared to their selenium analogues.
1,3,4,10,17
 As for the possible 
underlying biochemical causes of such high activity and selectivity (for tellurium as 
well as for HCT116 cells), a specific interaction of tellurium compounds with cellular 
targets, such as individual components of the intracellular thiolstat, or burst of 
reactive oxygen species (ROS) is most likely.
1,2,4,5,10,15,16,18–22
 Indeed, there are 
numerous reports that selenium as an antioxidant seems to be unable to induce a ROS 
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generating chemistry, which may also explain the rather low activity of the selenium 
compounds in our assays.
1,3,23,24
 
We have therefore investigated this possible ‘redox link’ between a tellurium 
compound and apoptosis in HCT116 cells in more detail.
15
 In the first instance, 
fluorescent staining of intracellular superoxide anion radicals (O2˙
−
) was performed 
using dihydroethidium (DHE) as a fairly specific probe for this particular radical.
15
 As 
expected, initial results confirm a sharp increase in intracellular O2˙
−
 levels in 
response to compounds such as DP41. At a concentration of 50 μM and within 40 min 
of application, this tellurium compound causes a significant increase of O2˙
−
 levels (in 
our preliminary experiments, the O2˙
−
 concentration measured by this method almost 
doubles). Similar increases in intracellular ROS levels have already been observed for 
quinone-containing organotellurium agents, and ultimately may lead to cell death via 
apoptosis.
5,10,15
 Indeed, our subsequent investigation of the effects of DP41 on the 
mitochondrial membrane potential ΔΨM using JC-1 as a dual colour red/green 
fluorescent reporter dye revealed a significant, time- and concentration-dependent 
decrease of ΔΨM in response to this tellurium compound (see Fig. 5 for a graphic 
evaluation of fluorescent data). Such a loss of mitochondrial membrane potential may 
form an important part of apoptotic processes resulting in cell death. It should be 
emphasized, however, that any – causal – relationship(s) between O2˙
−
 levels on the 
one side and ΔΨM, on the other, are not immediately obvious and require further 
investigation. Considering the timing of these events, i.e. less than 1 h for the increase 
in O2˙
−
 levels and evidently more than 2 h for the decrease in ΔΨM, it appears that the 
increase in ROS occurs prior to mitochondrial damage. This in turn points towards a 
redox event as the initial cause of activity and counts against a decisive amphiphilic 
interaction of compounds such as DP41 with the mitochondrial membrane. Indeed, 
the selenium-analogue of DP41, i.e. compound DP31, did not cause any significant 
increases in O2˙
−
 levels and also did not cause a major decrease in ΔΨM, hence 
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supporting the notion of a tellurium-specific activity which is linked to the generation 
of intracellular ROS. DP41 differs from previously used quinone-containing 
organotellurium compounds, and the build-up of O2˙
−
 occurs in the absence of a 
radical-generating quinone moiety. It may not be caused directly by the redox 
chemistry of DP41, but by a more indirect, secondary event, possibly mediated by 
cellular processes, such as ER stress. 
 
Fig 5. Time- and dose-dependent impact of DP31 and DP41 on the mitochondrial 
membrane potential (DMSO as the negative control). The fluorescent intensities 
of the green and red channels from 150 cells were integrated and final ratios of 
red to green calculated. Panel (a): DP41 (at 50 μM), but not DP31, causes a 
significant decrease in ΔΨM after 6 h of incubation. Panel (b): the impact of 
DP41 on ΔΨM is time- and dose-dependent. It manifests itself after around 6 to 8 
h and at concentrations from around 5 μM upwards. Data are presented as mean 
± SD, one-way ANOVA test (Dunnett), p < 0.05 (*), p < 0.01 (**) or p < 0.001 
(***). 
a)
b)
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While the initial results obtained in human RBCs, HCT116 and ARPE-19 cells are 
rather instructive, they may be due to specific interactions which occur – perhaps 
solely – in those cell types. We have therefore also considered the impact of such 
selenium and tellurium compounds on cultured RAW 264.7 macrophages (ATCC® 
TIB-71™). Macrophages were selected as an additional cell system because these 
immune cells naturally produce high levels of ROS and hence should provide a 
suitable target for compound-induced redox modulation.
1
 The results obtained in 
RAW 264.7 cells are summarized in Table 1 and shown for DP31 and DP41 in Fig. 4c. 
These results confirm the considerable cytotoxicity of DP41 (IC50 = 3.95 μM). Indeed, 
it seems that the macrophages are even slightly more sensitive to DP41 when 
compared to the HCT116 cells (IC50 = 5.99 μM), which may be due to the high ROS 
levels present naturally in and near such immune cells. A similar activity of 
tellurium-based redox modulators on macrophages has been observed previously.
1
 
While the precise cause of such activity is speculative at this time, it should be noted 
that the selenium analogue of DP41, i.e. DP31, as well as SDS, are both considerably 
less active against RAW 264.7 cells with IC50 values of over 100 μM. These findings 
support further the notion of a tellurium-based, redox modulating activity of 
compounds such as DP41, which is notably absent in the case of the corresponding 
selenium compounds or SDS. The specific activity of DP41, together with the low 
concentrations of this compound required, once more count against an amphiphilic 
interaction as the main cause of (cytotoxic) activity in proliferating human cell lines. 
The results obtained in isolated or cultured human cells may only provide a partial 
picture of the various biological activities and biochemical mode(s) of action 
associated with these compounds. It is known, for instance, that many 
chalcogen-based compounds also exhibit a pronounced activity against various 
bacteria and some redox sensitive parasites. Therefore initial screens for antibiotic 
activity against Staphylococcus aureus and Escherichia coli were performed, which 
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point towards some activity of the tellurium compounds when used at higher 
micromolar concentrations, which exceed the activity of the selenium analogues and 
SDS. DP41, which was among the most cytotoxic compounds in the case of cultured 
human cells, was also the most active compound against E. coli with an IC50 of 
around 550 μM. Nonetheless, antibacterial activity was weak when compared to the 
cytotoxicity against human cells. 
When DP31 and DP41 were tested in the context of the agricultural nematode 
Steinernema feltiae, a rather different picture emerged. S. feltiae is a parasitic 
nematode often used in initial toxicity screens, as this organism is easy to cultivate 
and also fairly reliable in producing representative and reproducible results.
25
 The 
nematicidal activities associated with DP31, DP41 and SDS are shown in Fig. S4 in 
the ESI.† SDS is only weakly active against S. feltiae (LD50 > 400 μM), counting 
against a particular sensitivity of this organism towards surfactants. Perhaps 
surprisingly, therefore, DP41 and especially DP31 are quite active against this 
organism. Interestingly, the selenium compound DP31 (LD50 = 30 μM) is even more 
active when compared to its tellurium analogue, DP41 (LD50 = 78 μM). The exact 
causes for this pronounced activity of DP31 – compared to DP41 – are still unclear. 
One may speculate that the selenium compound is taken up and metabolized to toxic 
metabolites more readily, as most organisms possess pathways for the metabolism of 
selenium compounds, but not for tellurium compounds. Indeed, the results obtained 
for our compounds in the four human cell models, the bacteria and nematodes confirm 
that such agents are not merely globally toxic but possess some selectivity which may 
result from their ability to enter cells and to act on particular cellular targets, be it on 
specific proteins or on a local or global redox state. 
Ultimately, our studies have shown that it is possible to synthesize a range of 
selenium- and tellurium-containing surfactants with comparable ease. As expected, 
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these molecules combine redox activity with amphiphilic properties and hence exhibit 
several advantages when compared to traditional redox modulators or surfactants. The 
compounds reported here are easy to handle, fairly soluble in aqueous solutions and 
endowed with considerable biological activity against a range of important therapeutic 
targets, such as certain cancer cells, macrophages, bacteria and a representative 
nematode. In fact, the activity determined so far compares well with that of so-called 
‘multifunctional’ redox modulators which combine a selenium or tellurium redox 
moiety with a quinone.
1,26
 While the latter require the presence of a radical generating 
quinone for adequate activity in the high nanomolar to low micromolar range, the 
compounds discussed here exhibit a similar, slightly lower activity yet do not require 
the presence of a cytotoxic quinone moiety. At the same time, the tellurium 
compounds, which are often more active than their selenium counterparts, show 
activity not only against HCT116 cancer cells, but also against RAW 264.7 
macrophages, S. feltiae and E. coli. 
This raises the question, why such compounds are active, and possibly even show 
some selectivity. Our initial experiments conducted to explore the underlying 
biochemical mode(s) of action point towards a combination of two activities. On the 
one hand, there is clearly an amphiphilic, probably non-covalent and disruptive 
interaction of these agents with membranes and proteins; on the other hand, the 
presence of tellurium (and less so selenium) seems to directly or indirectly enable 
these compounds to affect the cellular redox balance (as seen for O2˙
−
 levels) and 
maybe also cause a covalent modification of key proteins of the cellular thiolstat. 
While the amphiphilic events seem to occur only at higher concentrations (50 to 100 
μM and above) and do not discriminate significantly between the presence of 
selenium and tellurium, the redox interactions seem to be more or less specific for 
tellurium and occur at lower concentrations (10 to 50 μM in cultured human cells). 
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Extensive future studies are obviously required to investigate further the exact 
underlying biochemical mode(s) of action and to identify possible intracellular targets 
(such as specific organelles, membranes or proteins). At this point, the intracellular 
pathways triggered or influenced by such compounds also need to be mapped out in 
more detail. Ultimately, it will also be necessary to produce a wider range of such 
compounds, including some sulfur-containing analogues, and to screen for further 
activities and selectivity, also in order to derive reliable structure–activity 
relationships. Our initial results point towards a particularly promising spectrum of 
activities associated with the tellurium compounds, especially compound DP41, 
which may be considered as a lead compound emerging from these studies. As the 
structure of this compound provides considerable scope for modifications, and the 
synthesis of derivatives is now straightforward, a wider spectrum of additional 
compounds based on this initial lead appears possible. Here, it will be interesting to 
see if the presence of a quinone helper group will further enhance activity and/or 
selectivity, as has already been observed for a previous generation of such redox 
modulating compounds.
1,2,4,5,9,26
 
In the future, such compounds will be evaluated extensively for possible anticancer 
and antimicrobial activity. Cells and organisms which naturally produce high amounts 
of ROS (such as certain cancer or immune cells), or exhibit a weak antioxidant 
defence (such as certain parasites, including nematodes and Plasmodium falciparum), 
will obviously form the prime targets of such redox modulating agents.
6
 In any case, 
our findings bode well for the further development of such amphiphilic redox 
modulators as lead structures for the treatment of a range of human diseases and for 
possible agricultural applications. 
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2.1.6. Supplementary Information 
Synthesis of amphiphilic, chalcogen-based redox modulators with in vitro 
cytotoxic activity against cancer cells, macrophages and microbes 
2.1.6.1. Experimental Section 
All chemicals and solvents used were purchased from Acros Organic, Alfa Aesar or 
Sigma Aldrich as reagent grade and used without further purification. Melting points 
were determined with a Thermo Scientific Electrothermal Digital Melting Point 
Apparatus and are provided as uncorrected values. 
1
H and 
13
C NMR spectra were 
recorded with a Bruker AC or a Bruker Avance 500 spectrometer at 250 or 500 MHz 
in CDCl3 or DMSO-d6 as specified. 
77
Se spectra were measured with a Bruker Avance 
500 at 92.5 MHz in CDCl3 or DMSO-d6. All chemical shifts are reported in parts per 
million (ppm). Tetramethylsilane (TMS) and dimethylselenide were used as standard 
reference for 
1
H and 
13C (δ 0 ppm) and for 77Se, respectively. MS spectra were 
recorded on an Agilent Technologies GC-MS instrument equipped with a 7683 
injector, 6890N gas chromatograph and a 5973 mass selective detector. The mass 
spectrometer was operated in EI mode at 70 eV, and MS spectra were recorded from 
m/z 50 to 650. All reactions were routinely checked by TLC analysis on an Alugram 
SIL G/UV254 plate (Macherey-Nagel) with spots visualized by UV light. 
2.1.6.1.1. General Procedure for Synthesis of 1-Hydroalkylphenyl Selenide 
(Telluride)  
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1-Hydroalkylphenyl selenide was synthesized according to Han et al,
 
with some 
modifications.
1
 Briefly, diphenyl diselenide or diphenyl ditelluride (1 eq.) was 
dissolved in 20 ml of anhydrous THF under argon, and then 20 ml of an aqueous 
solution of 5.0 eq. sodium borohydride was added. The reaction mixture was stirred 
for 10 min until the solution turned colourless, indicating the formation of PhSeNa or 
PhTeNa, respectively. The PhSeNa or PhTeNa solution was stirred for a further 20 
min. A solution of a bromoalkylalcohol (2 eq.) in 5ml THF was then added to the 
reaction mixture and the reaction was kept at 50°C for 12 h under argon flow (for the 
telluride compound at 40°C). Then 50 ml of saturated aqueous NH4Cl solution was 
added to the reaction mixture and the product was extracted with CH2Cl2 (3×50ml). 
The organic layers were combined and dried with MgSO4, filtered, and the solvent 
was evaporated under vacuum. The oily solid obtained was purified by column 
chromatography with CH2Cl2 as the eluent. (Rf values of all compounds were between 
0.2 to 0.3)  
8-(phenylselanyl)octan-1-ol (DP11). Yield: 92%; white powder; mp 41°C; 
1
H NMR 
(500 MHz, CDCl3) δ 7.45-7.47 (m, 2H, benzene protons), 7.20-7.25 (m, 3H, benzene 
protons), 3.60-3.62 (t, 2H, J = 7Hz, -CH2OH), 2.87-2.90 (t, 2H, J = 7.5Hz, -SeCH2-), 
1.65-1.71 (m, 2H, -CH2CH2OH), 1.50-1.55 (m, 2H, -SeCH2CH2-), 1.25-1.40 (m, 8H, 
-(CH2)4CH2CH2OH) ppm; 
13
C NMR (125 MHz, CDCl3) δ 132.37 (2C), 130.64, 
128.96 (2C), 126.58, 63.01, 32.73, 30.09, 29.71, 29.23, 29.00, 27.90, 25.63 ppm; 
77
Se 
NMR (92.5 MHz, CDCl3) δ 291.02 ppm; HRMS (ESI) [M+H]+ C14H23OSe calcd 
287.0909, found 287.0916. 
9-(phenylselanyl)nonan-1-ol (DP12). Yield: 87%; white powder; mp 46°C; 
1
H NMR 
(500 MHz, CDCl3) δ 7.45-7.47 (m, 2H, benzene protons), 7.20-7.25 (m, 3H, benzene 
protons), 3.60-3.63 (t, 2H, J = 6.5Hz, -CH2OH), 2.87-2.90 (t, 2H, J = 7.5Hz, -SeCH2-), 
1.65-1.71 (m, 2H, -CH2CH2OH), 1.50-1.56 (m, 2H, -SeCH2CH2-), 1.25-1.39 (m, 10H, 
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-(CH2)5CH2CH2OH) ppm; 
13
C NMR (125 MHz, CDCl3) δ 132.37 (2C), 130.68, 
128.96 (2C), 126.58, 63.05, 32.77, 30.12, 29.78, 29.42, 29.32, 28.99, 27.93, 25.69 
ppm; 
77
Se NMR (92.5 MHz, CDCl3) δ 290.94 ppm; HRMS (ESI) [M+Na]
+
 
C15H24NaOSe calcd 323.0885, found 323.0917. 
10-(phenylselanyl)decan-1-ol (DP13). Yield: 96%; white powder; mp 52°C;
 1
H 
NMR (500 MHz, CDCl3) δ 7.45-7.47 (m, 2H, benzene protons), 7.20-7.25 (m, 3H, 
benzene protons), 3.60-3.63 (t, 2H, J = 6.5Hz, -CH2OH), 2.87-2.90 (t, 2H, J = 7.5Hz, 
-SeCH2-), 1.65-1.71 (m, 2H, -CH2CH2OH), 1.51-1.55 (m, 2H, -SeCH2CH2-), 
1.25-1.39 (m, 12H, -(CH2)6CH2CH2OH) ppm; 
13
C NMR (125 MHz, CDCl3) δ 132.35 
(2C), 130.69, 128.95 (2C), 126.56, 63.06, 32.78, 30.12, 29.79, 29.48, 29.38, 29.36, 
29.03, 27.93, 25.70 ppm; 
77
Se NMR (92.5 MHz, CDCl3) δ 290.96 ppm; HRMS (ESI) 
[M+H]
+ 
C16H27OSe calcd 315.1222, found 315.1223. 
11-(phenylselanyl)undecan-1-ol (DP14). Yield: 92%; white powder; mp 58°C; 
1
H 
NMR (500 MHz, CDCl3) δ 7.45-7.47 (m, 2H, benzene protons), 7.20-7.25 (m, 3H, 
benzene protons), 3.60-3.63 (t, 2H, J = 6.5Hz, -CH2OH), 2.87-2.90 (t, 2H, J = 7.5Hz, 
-SeCH2-), 1.65-1.71 (m, 2H, -CH2CH2OH), 1.51-1.57 (m, 2H, -SeCH2CH2-), 
1.24-1.39 (m, 14H, -(CH2)7CH2CH2OH) ppm; 
13
C NMR (125 MHz, CDCl3) δ 132.34 
(2C), 130.70, 128.95 (2C), 126.56, 63.06, 32.79, 30.12, 29.80, 29.54, 29.46, 29.44, 
29.39, 29.05, 27.94, 25.71 ppm; 
77
Se NMR (92.5 MHz, CDCl3) δ 290.94 ppm; HRMS 
(ESI) [M+H]
+
 C17H29OSe calcd 329.1379, found 329.1384. 
12-(phenylselanyl)dodecan-1-ol (DP15). Yield: 85%; white powder; mp 63°C, 
1
H 
NMR (500 MHz, CDCl3) δ 7.45-7.47 (m, 2H, benzene protons), 7.20-7.24 (m, 3H, 
benzene protons), 3.60-3.63 (t, 2H, J = 6.5Hz, -CH2OH), 2.87-2.90 (t, 2H, J = 6.5Hz, 
-SeCH2-), 1.65-1.69 (m, 2H, -CH2CH2OH), 1.53-1.56 (m, 2H, -SeCH2CH2-), 
1.23-1.39  (m, 16H, -(CH2)8CH2CH2OH) ppm; 
13
C NMR (125 MHz, CDCl3) δ 
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132.34 (2C), 130.70, 128.95 (2C), 126.56, 63.08, 32.80, 30.13, 29.81, 29.56, 29.52 
(2C), 29.46, 29.41, 29.05, 27.94, 25.72; 
77
Se NMR (92.5 MHz, CDCl3) δ 290.94 ppm; 
HRMS (ESI) [M+H]
+ 
C18H31OSe calcd 343.1535, found 343.1539. 
8-(phenyltellanyl)octan-1-ol (DP21). Yield: 97%; orange oil; 
1
H NMR (500 
MHz,CDCl3) δ 7.75-7.77 (m, 2H, benzene protons), 7.23-7.33 (m, 3H, benzene 
protons), 3.64-3.67 (t, 2H, J = 6.5Hz, -CH2OH), 2.93-2.96 (t, 2H, J = 7.5Hz, 
-TeCH2-), 1.81-1.87 (m, 2H, -CH2CH2OH), 1.62-1.56 (2H, m, -TeCH2CH2-), 
1.32-1.44 (m, 8H, - (CH2)4CH2CH2OH) ppm; 
13
C NMR (125 MHz, CDCl3) δ 138.11 
(2C), 128.99 (2C), 127.31, 111.73, 62.78, 32.60, 31.74, 31.63, 29.15, 28.74, 25.56, 
8.67 ppm; HRMS (ESI) [M+H]
+
 C14H23OTe calcd 337.0806, found 337.0812. 
9-(phenyltellanyl)nonan-1-ol (DP22). Yield: 95%; orange oil; 
1
H NMR (500 MHz, 
CDCl3) δ 7.75-7.77 (m, 2H, benzene protons), 7.23-7.33 (m, 3H, benzene protons), 
3.66-3.68 (t, 2H, J = 6.5Hz, -CH2OH), 2.93-2.96 (t, 2H, J = 7.5Hz, -TeCH2-), 
1.83-1.87 (m, 2H, -CH2CH2OH), 1.57-1.63 (m, 2H, -TeCH2CH2-), 1.31-1.43 (m, 10H, 
-(CH2)5CH2CH2OH) ppm; 
13
C NMR (125 MHz, CDCl3) δ 138.17 (2C), 129.04 (2C), 
127.36, 111.78, 62.80, 32.70, 31.84, 31.69, 29.36, 29.27, 28.76, 25.65, 8.74 ppm. 
HRMS (ESI) [M+H]
+ 
C15H25OTe calcd 351.0962, found 351.0958. 
10-(phenyltellanyl)decan-1-ol (DP23). Yield: 96%; orange oil; 
1
H NMR (250 MHz, 
CDCl3) δ 7.69-7.73 (m, 2H, benzene protons), 7.16-7.30 (m, 3H, benzene protons), 
3.62-3.66 (t, 2H, J = 5Hz, -CH2OH), 2.87-2.93 (t, 2H, J = 7.5Hz, -TeCH2-), 1.74-1.85 
(m, 2H, -CH2CH2OH), 1.51-1.59 (m, 2H, -TeCH2CH2-), 1.26-1.43 (m, 12H, 
-(CH2)6CH2CH2OH) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 138.37 (2C), 128.73 (2C), 
126.85, 111.82, 63.05, 32.78, 31.90, 31.75, 29.49, 29.38, 28.86, 29.37, 25.70, 8.78 
ppm; HRMS (ESI) [M+H]
+
 C16H27OTe calcd 365.1119, found 365.1120. 
Result and Discussion 
 
64 
 
11-(phenyltellanyl)undecan-1-ol (DP24). Yield: 98%; white powder; mp 39°C;
1
H 
NMR (500 MHz, DMSO-d6) δ 7.63-7.65 (m, 2H, benzene protons), 7.20-7.28 (m, 3H, 
benzene protons), 3.35-3.38 (m, 2H, -CH2OH), 2.88-2.91 (t, 2H, J = 7Hz, -TeCH2-), 
1.69-1.75 (m, 2H, -CH2CH2OH), 1.36-1.41 (m, 2H, -TeCH2CH2-), 1.21-1.34 (m, 14H, 
-(CH2)7CH2CH2OH) ppm; 
13
C NMR (125 MHz, DMSO-d6) δ 137.06 (2C), 129.24 
(2C), 127.18, 112.06, 60.71, 32.52, 31.15 (2C), 29.02, 28.91, 28.88, 28.84, 28.21, 
25.47, 8.21 ppm; HRMS [M+H]
+ 
C17H29OTe calcd 379.1275, found 379.1266. 
12-(phenyltellanyl)dodecan-1-ol (DP25). Yield: 90%; yellow powder; mp 43°C; 
1
H 
NMR (250 MHz, CDCl3) δ 7.69-7.72 (m, 2H, benzene protons), 7.16-7.30 (m, 3H, 
benzene protons), 3.62-3.67 (t, 2H, J = 7.5Hz, -CH2OH), 2.87-2.93 (t, 2H, J = 7.5Hz, 
-TeCH2-), 1.74-1.85 (2H, m, -CH2CH2OH), 1.51-1.57 (m, 2H, -TeCH2CH2-), 
1.25-1.43 (m, 16H, -(CH2)8CH2CH2OH) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 138.21 
(2C), 129.07 (2C), 127.39, 111.82, 63.09, 32.80, 31.92, 29.56, 29.45, 29.40, 29.29, 
29.13, 29.04, 28.88, 25,72, 8.79 ppm; HRMS (ESI) [M+H]
+
 C18H31OTe calcd 
393.1432, found 393.1428. 
2.1.6.1.2. General Procedure for Synthesis of sodium phenylselanyl-alkyl sulfate. 
1-Hydroalkylphenyl selenide or telluride (1eq.) was dissolved in 25ml anhydrous 
diethyl ether, then 1.5 eq. chlorosulfonic acid was added dropwise cautiously under 
nitrogen gas at 0°C for 10 min. The reaction mixture was stirred for a further 30 min. 
1.0 eq of NaHCO3 powder was added to the reaction mixture, then water was added 
dropwise until no further gas developed. The organic mixture was dried with MgSO4. 
The remaining solid was separated, washed with anhydrous diethyl ether several times 
and the compound contained therein was resolubilized using 250 ml ethanol. The 
residual MgSO4 and NaHCO3 were removed by filtration. The solvent was evaporated 
and the product collected. 
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Sodium 8-(phenylselanyl)octyl sulfate (DP31). Yield: 69%; white powder; mp 
112°C; 
1
H NMR (500 MHz, DMSO-d6) δ 7.44-7.46 (m, 2H, benzene protons), 
7.21-7.30 (m, 3H, benzene protons), 3.34-3.38 (m, 2H, -CH2OSO3Na), 2.92-2.95 (t, 
2H, J = 7.5Hz, -SeCH2-), 1.59-1.62 (m, 2H, -CH2CH2OSO3Na, 1.33-1.42 (m, 2H, 
-SeCH2CH2-), 1.20-1.26 (m, 8H, -(CH2)5CH2CH2OSO3Na) ppm; 
13
C NMR (125 MHz, 
DMSO-d6) δ 131.29 (2C), 130.28, 129.15 (2C), 126.37, 60.69, 29.50, 28.97, 28.90, 
28.84, 28.40, 26.65, 25.47; 
77
Se NMR (92.5 MHz, DMSO-d6) δ 283.17 ppm; HRMS 
(ESI) [M-Na]
-
 C14H21O4SSe calcd 365.0331, found 365.0337. 
Sodium 9-(phenylselanyl)nonyl sulfate (DP32). Yield, 84%; white powder; mp 
122°C; 
1
H NMR (500 MHz, DMSO-d6) δ:7.43-7.46 (m, 2H, benzene protons), 
7.21-7.30 (m, 3H, benzene protons), 3.64-3.67 (t, 2H, J = 6.5Hz, -CH2OSO3Na), 
2.92-2.95 (t, 2H, J = 7.5Hz, -SeCH2-), 1.59-1.65 (m, 2H, -CH2CH2OSO3Na), 
1.42-1.51 (2H, m, -SeCH2CH2-), 1.18-1.36 (m, 10H, -(CH2)5CH2CH2OSO3Na) ppm; 
13
C NMR (125 MHz, DMSO-d6) δ 131.31 (2C), 130.26, 129.17 (2C), 126.38, 65.41, 
29.51, 29.04, 29.01, 28.84, 28.64, 28.35, 26.64, 25.46 ppm;
77
Se NMR (92.5 MHz, 
DMSO-d6) δ 283.17 ppm; HRMS (ESI) [M-Na]
- 
C15H23O4SSe calcd 365.0337, found 
365.0331. 
Sodium 10-(phenylselanyl)decyl sulfate (DP33). Yield, 81%; white powder; mp 
125°C; 
1
H NMR (500 MHz, DMSO-d6) δ 7.43-7.45 (m, 2H, benzene protons), 
7.22-7.29 (m, 3H, benzene protons), 3.65-3.68 (t, 2H, J = 6.5Hz, -CH2OSO3Na), 
2.91-2.94 (t, 2H, J = 7.5Hz, -SeCH2-), 1.58-1.64 (m, 2H, -CH2CH2OSO3Na), 
1.43-1.48 (m, 2H, -SeCH2CH2-), 1.22-1.36 (m, 12H, -(CH2)6CH2CH2OSO3Na) ppm; 
13
C NMR (125 MHz, DMSO-d6) δ: 131.30 (2C), 130.25, 129.17 (2C), 126.38, 65.45, 
29.49, 29.03, 28.88, 28.82, 28.71, 28.37, 26.64, 25.48; 
77
Se NMR (92.5 MHz, 
DMSO-d6) δ 283.15 ppm; HRMS (ESI) [M-Na]
- 
C16H25O4SSe calcd
 
393.0644, found 
393.0671. 
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Sodium 11-(phenylselanyl)undecyl sulfate (DP34). Yield, 73%; white powder; mp 
130°C; 
1
H NMR (500 MHz, DMSO-d6) δ 7.44-7.46 (m, 2H, benzene protons), 
7.21-7.30 (m, 3H, benzene protons), 3.65-3.67 (t, 2H, J = 7Hz, -CH2OSO3Na), 
2.92-2.95 (t, 2H, J = 7.5Hz, -SeCH2-), 1.65-1.57 (m, 2H, -CH2CH2OSO3Na), 
1.44-1.49 (m, 2H, -SeCH2CH2-), 1.19-1.37 (m, 14H, -(CH2)7CH2CH2OSO3Na) ppm; 
13
C NMR (125 MHz, DMSO-d6) δ , 132.61, 131.30, 130.67, 129.94, 129.61, 128.67, 
65.33, 32.49, 28.97, 28.79, 28.74, 28.60, 28.56, 28.49, 28.20, 28.08, 25.40 ppm; 
77
Se 
NMR (92.5 MHz, DMSO-d6) δ 283.24 ppm; HRMS (ESI) [M-Na]
-
 C17H27O4SSe 
calcd 407.0801, found 407.0815. 
Sodium 12-(phenylselanyl)dodecyl sulfate (DP35). Yield: 96%; colourless solid; 
mp 137°C; 
1
H NMR (500 MHz, DMSO-d6) δ 7.43-7.46 (m, 2H, benzene protons), 
7.21-7.31 (m, 3H, benzene protons), 3.65-3.68 (t, 2H, J = 6.5Hz, -CH2OSO3Na), 
2.92-2.95 (t, 2H, J = 7.5Hz, -SeCH2-), 1.58-1.64 (m, 2H, -CH2CH2OSO3Na), 
1.44-1.50 (m, 2H, -SeCH2CH2-), 1.22-1.36 (m, 14H, -(CH2)7CH2CH2OSO3Na) ppm; 
13
C NMR (125 MHz, DMSO-d6) δ 131.29 (2C), 130.27, 129.16 (2C), 126.37, 65.42, 
29.49, 29.05, 29.00, 28.99, 28.95, 28.90, 28.86, 28.75, 28.38, 26.64, 25.50 ppm; 
77
Se 
NMR (92.5 MHz, DMSO-d6) δ 283.15 ppm; HRMS (ESI) [M-Na]
-
 C18H29O4SSe 
calcd
 
421.0957, found 421.1003. 
Sodium 8-(phenyltellanyl)octyl sulfate (DP41). Yield: 65%; orange powder; mp 
108°C; 
1
H NMR (250 MHz, CDCl3) δ 8.17-8.15 (m, 2H, benzene protons), 7.59-7.54 
(m, 3H, benzene protons), 4.38-4.25 (m, 2H, -CH2OSO3Na), 3.86-3.57 (m, 2H, 
-TeCH2-), 2.26-2.23 (m, 2H, -CH2CH2OSO3Na), 1.80-1.77 (m, 2H, -TeCH2CH2-), 
1.43-1.27 (m, 8H, -(CH2)5CH2CH2OSO3Na) ppm; 
13
C NMR (125 MHz, DMSO-d6) δ 
133.01, 132.75, 132.57, 129.31, 128.96, 128.72, 65.42, 30.97, 30.67, 29.07, 28.61, 
28.47, 28.39, 25.42, 25.38 HRMS (ESI) [M-Na]
-
 C14H21O4STe calcd 415.0227, found 
415.0248. 
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Sodium 9-(phenyltellanyl)nonyl sulfate (DP42). Yield: 85%; orange powder; mp 
124°C; 
1
H NMR (250 MHz, CDCl3) δ 8.16 (m, 2H, benzene protons), 7.58 (m, 3H, 
benzene protons), 4.35 (m, 2H, -CH2OSO3Na), 3.79 (m, 2H, -TeCH2-), 2.28 (m, 2H, 
-CH2CH2OSO3Na), 1.80 (m, 2H, -TeCH2CH2-), 1.57-1.39 (m, 10H, 
-(CH2)5CH2CH2OSO3Na); 
13
C NMR (62.5 MHz, CDCl3) δ 133.28 (2C), 131.87, 
131.77, 130.13-129.89 (2C), 70.48, 31.01, 30.79, 29.16, 28.82, 28.68, 25.54, 25.27, 
25.10; HRMS (ESI) C15H23O4STe calcd [M-Na]
- 
429.0383, found 429.0380. 
Sodium 10-(phenyltellanyl)decyl sulfate (DP43). Yield: 81%; orange powder; mp 
127°C; 
1
H NMR (250 MHz, CDCl3) δ 8.17-8.15 (m, 2H, benzene protons), 7.83-7.56 
(m, 3H, benzene protons), 4.22 (m, 2H, -CH2OSO3Na), 3.79-3.75 (t, 2H, J = 5 Hz, 
-TeCH2-), 2.27-2.24 (m, 2H, -CH2CH2OSO3Na), 1.74 (m, 2H, -TeCH2CH2-), 
1.55-1.33 (m, 12H, -(CH2)6CH2CH2OSO3Na) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 
133.26, 133.09, 132.16, 131.78, 130.53, 130.07, 70.17, 31.05, 29.37, 29.27, 29.17, 
28.89, 25.64, 25.27, 24.67; HRMS (ESI) [M-Na]- C16H25O4STe calcd 443.0540, 
found 443.0530. 
Sodium 11-(phenyltellanyl)undecyl sulfate (DP44). Yield: 83%; orange powder; 
mp 131°C; 
1
H NMR (250 MHz, CDCl3) δ 8.17-8.16 (m, 2H, benzene protons), 
7.58-7.57 (m, 3H, benzene protons), 4.31 (m, 2H, -CH2OSO3Na), 3.80-3.76 (t, 2H, J 
= 5 Hz, -TeCH2-), 2.27-2.24 (m, 2H, -CH2CH2OSO3Na), 1.78 (m, 2H, -TeCH2CH2-), 
1.42-1.26 (m, 14H, -(CH2)7CH2CH2OSO3Na) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 
133.28, 133.19, 132.01, 131.77, 130.21, 130.07, 70.48, 31.05, 30.71, 29.41, 29.33, 
29.21, 28.90, 28.65, 25.51, 25.28, 24.96 ppm; HRMS (ESI) [M-Na]
-
 C17H27O4STe 
calcd 457.0696, found 457.0676. 
Sodium 12-(phenylselanyl)dodecyl sulfate (DP45). Yield: 92%; orange powder; mp 
135°C; 
1
H NMR (250 MHz, CDCl3) δ 8.18-8.15 (m, 2H, benzene protons), 7.58-7.56 
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(m, 3H, benzene protons), 4.26 (m, -CH2OSO3Na), 3.79-3.76 (t, 2H, J = 5 Hz, 
-TeCH2-), 2.27-2.24 (t, 2H, J = 5 Hz, -CH2CH2OSO3Na), 1.76 (m, 2H, -TeCH2CH2-), 
1.41-1.31 (m, 16H, -(CH2)8CH2CH2OSO3Na) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 
137.73, 133.76, 133.10 (2C), 132.61, 130.54, 70.05, 35.14 (2C), 31.10, 30.50, 29.71, 
29.43 (2C), 29.28, 28.53, 24.76 (2C) ppm; HRMS (ESI) [M-Na]
-
 C18H29O4STe calcd 
471.0853 found 471.0837. 
2.1.6.2. Surface activity and Critical Micelle Concentration (CMC) measurements 
Compounds were dissolved in double-distilled water and the final concentrations used 
for this experiment were as follows: 0.025 mM, 0.25 mM, 0.5 mM, 1 mM, 5 mM and 
10 mM. This experiment was carried out with a KRÜSS Tensiometer K6 (KRÜSS 
GmbH, Hamburg) according to the manufacturer’s instructions.  
2.1.6.3. Cyclic voltammetry 
Cyclic Voltammograms were recorded at a BAS CV-100W electrochemical 
workstation. In all electrochemical experiments, a glassy carbon electrode was used as 
a working electrode, an Ag/AgCl electrode (SSE) as reference and a platinum spiral 
as counter electrode. For the electrochemical studies, the electrolysis cell containing 
33% methanolic 50 mM potassium phosphate buffer, pH 7.4, with in a final 
concentration of 250 µM of compound was used. The potential range was varied 
between -800 to 800 mV, with a scan rate of 500 mVs
-1
. Four full cycles were 
recorded and the first cycle was used to identify the respective peak potentials. All 
experiments were preformed in triplicate at room temperature. To obtain oxygen-poor 
conditions, the electrolysis cell was purged with nitrogen before each measurement.  
2.1.6.4. Haemolysis Assay 
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Drabkin’s reagent kit (Sigma) was used for the haemolysis assay. All compounds 
were dissolved in DMSO (100 mM stock solutions). Stock solutions were diluted with 
DMSO to obtain a dilution series of 100 µM, 1 mM and 10 mM. The RBCs sample 
consisted of 990µl HPS buffer (NaCl 145 mM, KCl 7.5 mM, glucose 10 mM, HEPES 
10 mM, pH 7.4). 10 µl of each compound were tested with 2.5 % haematocrit. The 
final concentrations of the compounds tested were 1 µM, 10 µM, 100 µM and 1 mM. 
The DMSO concentration in every sample was 1%. A negative control was used 
consisting of 990 µl HPS buffer and 10 µl DMSO with 2.5 % haematocrit. SDS 
served as a positive control. The RBC samples were incubated for 30 min at 37︒C in 
a water bath. After incubation, the samples were centrifuged at 12,000 g for 30 s, the 
500 µl supernatant for each concentration was transferred into 2 ml of Drabkin’s 
solution. The supernatant of the positive control was transferred into 2 ml of 
Drabkin’s solution with detergent to lyse all RBCs in the sample. After incubation of 
the samples at room temperature for 30 min in the dark, the absorption at 540 nm was 
measured with a UV-Vis spectrophotometer (UV mini 1240, UV-Vis 
Spectrophotometer, Shimadzu). Three different whole blood samples were used for 
each experiment. 
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Fig S1. Impact of compounds on the membranes of RBCs. SDS was used as a positive 
control. 
2.1.6.5. Circular dichroism measurement (CD) 
CD spectra were measured at 20°C on a Jasco J720 spec-tropolarimeter (Jasco 
Corporation, Tokyo, Japan). For the determination of the interaction between 
compounds and proteins, samples contained 50 µM haemoglobin (Sigma) in 995µl 
potassium phosphate buffer (10mM, pH 7.4) and 5 µl of each compound in DMSO 
(10mM) or 20 µM Adx in 995 µl potassium phosphate buffer (10mM, pH 7.4) and 5 
µl of each compound in DMSO (1mM stock solution) as well as 5 µl DMSO as 
negative control in 1 cm cuvette for measurements in the range of 250 to 650 nm. The 
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spectra were accumulated 3 times and then smoothed. The spectrum of the potassium 
phosphate buffer was recorded in each case and respectively saved as a baseline. 
 
 
Fig S2. Interaction of selected compounds with proteins. SDS was used as 
positive control. a) haemoglobin b) Adx. 
2.1.6.6. Cell culture 
p53-Positive HCT116 wt cells were maintained at 37°C and 5% CO2 in McCoy’s 5A 
medium (PromoCell, Heidelberg, Germany) with 10% fetal calf serum (FCS). 
ARPE-19 cells were maintained at 37°C and 5% CO2 in DMEM medium (PromoCell, 
Heidelberg, Germany) with 10% fetal calf serum (FCS). RAW 264.7 cells were 
cultured at 37 °C and 5% CO2 in RPMI 1640 medium (PromoCell, Heidelberg, 
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Germany). Organic selenide and telluride compounds were dissolved in DMSO as a 
100 mM stock solution which was freshly prepared before use.  
2.1.6.7. Reflection electron microscope (REM) and Energy-dispersive X-ray 
spectroscopy (EDX)  
HCT116 cells were grown on coverslips until they were 50% confluent, washed with 
warm PBS (PH 7.4), treated with 50 µM organic selenide and telluride compounds 
and as negative control with same amount of DMSO. After incubations for 48 h, cells 
were fixed with 0.2 M cacodylate buffer containing 1% formaldehyde. Continuously 
increasing concentrations of ethanol were used for dehydration for 24 h. The fixed 
cells were coated with gold on a coverslip. REM and EDX analyses were recorded 
with a SUPRA
TM
 40 (Carl Zeiss AG, Germany). 
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Fig S3. HCT 116 cells were treated with compound DP41 for 48 h as well as 
with DMSO as negative control. a) and b) REM analysis with EDX analysis to 
detect Te atoms in the cells. Cells were treated with DMSO (a) as well as with 
DP41 (b). c) Detection of tellurium inside the cell using two different detectors 
(the SE-detector is used for cell surface imaging, the AsB detector for 
crystallographic contrast). d) Tellurium mapping to show the distribution of the 
tellurium in the cells. 
a)
d) Te elemtar mapping Merge
SE detector AsB detector
AsB detector
b)
c)
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2.1.6.8. Evaluation of cell viability 
In order to determine the effect of organic selenide and telluride compounds on 
HCT116, ARPE-19 cells or RAW 264.7, cells were seeded at 10
4
 cells per well to a 
final volume of 200 µl in a 96-well plate and incubated overnight. Cells were then 
incubated with various concentrations of organic selenide and telluride compounds for 
24h. Viability of the cells was determined by a colorimetric MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium, Sigma) assay according to the 
manufacturer’s instructions. 1 hour before the end of treatment, 50 µl MTT (5 mg/ml 
PBS) were added at 37 °C in a humified atmosphere. Following 1 h MTT treatment, 
the medium was removed and disposed and cells solubilized by adding 200 µl pure 
DMSO each well to allow the formazan crystals to dissolve completely. The 
spectrophotometrical absorbance of the purple-blue formazan dye was determined 
with an absorbance reader at 595 nm. 
2
 
2.1.6.9. JC-1 assay for estimating the mitochondrial membrane potential ΔΨM 
Cells were plated onto coverslips with a density of 5×10
3 
cells/coverslip and cultured 
for 24 h before further treatment. At this point, cells were treated with different 
concentrations of compounds for 2, 6 or 8 h. After cells were washed three times with 
Tyrode buffer (see above), they were incubated with 10 µg/ml JC-1 dye for 30 min. 
Subsequently, cells were washed three times with Tyrode buffer to remove any excess 
of dye. The coverslips were then mounted on a microscope (Karl Zeiss, Germany) and 
illuminated at 488 nm and 519 nm. The green and red channels of the fluorescence 
emitted were recorded. The fluorescence intensities of green and red channels from 
150 cells were integrated, respectively, and the final ratios of red to green 
fluorescence were calculated for further statistic analysis. 
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2.1.6.10. Nematode Assay 
The nematode assay based on S. feltiae is used to screen the toxicity of compounds 
against smaller organisms, especially against nematodes. S. feltiae were purchased 
from Sautter & Stepper, Germany. The nematodes were prepared and assayed as 
described previously. 
3
 Different concentrations of compounds were added (final 
concentrations of 50, 100, 200, and 400 µM in 1 % of DMSO in water). The viability 
of the nematodes was determined after 24 h of treatment, the control containing 1 % 
DMSO was set at 100 % viability and LD50 values were calculated accordingly. 
 
Fig S4. Nematicidal activity of selected compounds against S. feltiae. Nematodes 
were treated with different concentrations of SDS, DP31 and DP41 for 24 h. 
Significances are expressed to the control (1% DMSO in water). Data shown as 
means of three independent experiments. (* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001). 
***
*** ***
***
***
*** ***
***
(4)DP31 DP41
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2.1.6.11. Bacterium-Inhibition Assay 
Staphyllococcus aureus WDCM 5233 was obtained from Microbiological Depository 
Centre, Armenia and Escherichia coli M17 VKPM-B8208 from the Russian National 
Collection of Industrial Microorganisms. Bacteria were cultured on agar plates 
according to standard procedures. The diameters of the inhibitory zones were 
measured in mm. The minimal antibacterial activity was taken according to the 
diameter of the absence of bacterial growth zones, not less than 12 mm. The MIC 
(minimum inhibitory concentrations) was calculated with the corresponding optical 
density measurements at 595nm. 
2.1.6.12. Statistics 
GraphPad Prism software (GraphPad Inc., USA) was used for statistical analysis. 
Results were expressed as the mean ±SEM. Differences between the experimental 
groups were analyzed using one-way ANOVA test (Dunnett) or Student’s t-test 
(two-tail, unpaired). Statistical significance categories are shown as: p ˂ 0.05 (*), p ˂ 
0.01 (**) or p ˂ 0.001 (***). 
2.1.6.13. Additional Literature for the ESI  
1. P. Han, N. Ma, H. Ren, H. Xu, Z. Li, Z. Wang and X. Zhang, Langmuir : the 
ACS journal of surfaces and colloids, 2010, 26, 14414-14418. 50  
2. M. Doering, B. Diesel, M. C. H. Gruhlke, U. M. Viswanathan, D. Manikova, M. 
Chovanec, T. Burkholz, A. J. Slusarenko, A. K. Kiemer and C. Jacob, Tetrahedron, 
2012, 68, 10577-10585.  
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3. B. Czepukojc, U. M. Viswanathan, A. Raza, S. Ali, T. Burkholz and C. Jacob, 
Phosphorus Sulfur and Silicon and the Related Elements, 2013, 188, 446-453.   
  
Result and Discussion 
 
78 
 
2.2. Publication 2 
A new tellurium-containing amphiphilic molecule induces apoptosis in HCT116 
colon cancer cells 
Peng Du, Nathaniel Edward Bennett Saidu, Johanna Intemann, Claus Jacob, Mathias 
Montenarh 
This manuscript was published as an article in the following Journal: 
Biochimica et Biophysica Acta 1840 (2014) 1808–1816 
DOI: 10.1016/j.bbagen.2014.02.003 
 
2.2.1. Abstract 
2.2.1.1. Background 
Chalcogen-based redox modulators over the years have attracted considerable 
attention as anti-cancer agents. New selenium- and tellurium-containing compounds 
with a polar head group and aryl-groups of various lengths have recently been 
reported as biologically active in several organisms. In the present study, we used the 
most active of the tellurium compound DP41, and its selenium counterpart DP31 to 
investigate their effects on the human cancer cell line HCT116. 
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2.2.1.2. Methods 
Cells were treated with DP41 or DP31 and the formation of superoxide radicals was 
determined using dihydroethidium. Cell cycle analysis and apoptosis was determined 
by cytofluorimetry. Proteins involved in ER signaling and apoptosis were determined 
by Western blot analysis and fluorescence microscopy. 
2.2.1.3. Results 
With 50 μM of DP41, we observed an increase in O2˙
−
 formation. There was, however, 
no such increase in O2˙
−
 after treatment with the corresponding selenium compound 
under the same conditions. In the case of DP41, the production of O2˙
−
 radicals was 
followed by an up-regulation of Nrf2, HO-1, phospho-eIF2α and ATF4. CHOP was 
also induced and cells entered apoptosis. Unlike the cancer cells, normal retinal 
epithelial ARPE-19 cells did not produce elevated levels of O2˙
− 
radicals nor did they 
induce the ER signaling pathway or apoptosis. 
2.2.1.4. Conclusions 
The tellurium-containing compound DP41, in contrast to the corresponding selenium 
compound, induces O2˙
−
 radical formation and oxidative and ER stress responses, 
including CHOP activation and finally apoptosis. 
2.2.1.5. General significance 
These results indicate that DP41 is a redox modulating agent with promising 
anti-cancer potentials. 
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2.2.2. Introduction 
Organosulfur-containing compounds have had a prominent role in medicine since 
ancient times [1-3]. There is a comprehensive literature in particular on 
sulfur-containing compounds derived from garlic, onions and leek [4-7]. Against this 
background, the medicinal applications of other members of the chalcogen family, 
namely selenium and tellurium compounds, are clearly still in their infancy. Selenium 
is an essential trace element which is involved in a variety of different functions in the 
human body [8]. Furthermore, selenium seems to play a role in cancer prevention and 
treatment. In contrast to selenium, tellurium does not have any known natural 
biological function in the human body. One of the reasons for this difference may be 
that tellurium–carbon bonds are more labile than their selenium counterparts and so 
bond cleavage occurs much more readily [9]. There are many reports on efforts which 
have been directed towards the evaluation of synthetic selenium compounds for 
pharmaceutical applications [10], but only a very limited number of attempts are 
known for synthetic tellurium compounds. Some of the compounds studied so far 
exhibit anti-fungal, anti-bacterial and anti-malarial activities [11-12] . Many of these 
applications, but not all, rely on an inherent redox modulating ability of selenium and 
tellurium. Unfortunately, many of the most interesting organoselenium or 
organotellurium compounds are poorly water soluble and unstable and hence 
inappropriate to test in a biological context. On the other hand, highly water-soluble 
compounds have only a limited capability to cross the plasma membrane and to 
penetrate into cells. Thus, bioavailability of such agents is usually limited. About a 
decade ago, first attempts on the synthesis of amphiphilic selenium and tellurium 
compounds with an anionic head group and different hydrophilic tail lengths were 
published. These compounds were tested for their protective activity against oxidation 
and nitration reactions caused by peroxynitrite [13]. Furthermore, the catalytic activity 
of these compounds towards the peroxidation of the zinc-containing protein 
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metallothionein was investigated. Recently, newly designed tellurium-containing 
compounds were used to monitor in vivo redox reactions between peroxynitrite and 
glutathione [14]. Other new tellurium compounds have also been used for the 
detection of reactive oxygen species [15]. Both these detection systems utilize the 
redox properties of the tellurium atom. On the other hand, new tellurium-containing 
pyrylium compounds were tested as modulators of the activity of multidrug resistance 
proteins [16-17]. It turned out that the electronegativity of the chalcogen determines 
whether these compounds act as inhibitors or activators of the multidrug resistance 
proteins. A whole series of new organoselenium and organotellurium compounds with 
different aryl-side chains have recently been synthesized and initially characterized 
[18]. At the same time, chalcogen nanoparticles have been used successfully 
providing further impetus for the development of more sophisticated self-assembling 
tellurium agents. In general, it was found that the tellurium compounds are more 
potent than the corresponding selenium compounds with regard to a reduction in cell 
viability and killing of bacteria. In the present study, we used the most potent 
compounds and tested their ability to induce cell death in cancer cells. Moreover, we 
analyzed cellular signaling pathways leading to growth arrest and eventually to 
apoptosis. We found that the organotellurium compound DP41 generates O2˙
−
 radicals 
in cancer cells. The production of O2˙
−
 radicals is followed by the activation of the ER 
signaling pathway which finally results in the induction of apoptosis. In contrast, 
normal retinal pigment epithelial (ARPE-19) cells failed to produce any significant 
amounts of O2˙
− 
radicals in response to DP41 treatment and consequently there was 
no induction of apoptosis in these cells. 
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2.2.3. Materials and methods 
2.2.3.1. Reagents and antibodies 
Protease inhibitor cocktail Complete™ (Roche Diagnostics, Mannheim, Germany), 
ascorbic acid (ASC) and anti-α-tubulin antibodies were obtained from Sigma-Aldrich 
(Munich, Germany). DMSO was from Merck (Darmstadt, Germany). Antibodies 
against CHOP (GADD153), cytochrome c, γH2AX, GAPDH and Nrf2 were 
purchased from Santa Cruz Biotechnology (Heidelberg, Germany). 
Anti-poly(ADP-ribose) polymerase (anti-PARP), anti-ATF4, anti-eIF2α, 
anti-phospho-eIF2α (Ser 51) and anti-HO-1 antibodies were purchased from Cell 
Signaling Technology (Frankfurt, Germany), while the caspase 3 antibody was 
purchased from Promega (Mannheim, Germany). Goat, mouse and rabbit secondary 
antibodies were all bought from Dianova (Hamburg, Germany). Organic selenide 
DP31 and telluride DP41 compounds were synthesized and described recently [18]. 
They were dissolved in DMSO to a 100 mM stock solution which was freshly 
prepared before use. Ascorbic acid was dissolved in distilled water to a 100 mM stock 
solution and applied to the cell culture medium 0.5 h (unless stated otherwise) before 
treatment with chalcogen compounds. 
2.2.3.2. Cell culture 
HCT116 cells were maintained at 37 °C and 5% CO2 in McCoy's 5A medium 
(PromoCell, Heidelberg, Germany) with 10% fetal calf serum (FCS). ARPE-19 cells 
were maintained at 37 °C and 5% CO2 in DMEM medium (PromoCell, Heidelberg, 
Germany) with 10% FCS. The androgen-sensitive prostate cancer cells, LNCaP, were 
maintained at 37 °C in RPMI 1640 media, supplemented with 10% FCS in an 
atmosphere enriched with 5% CO2. 
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2.2.3.3. Tubulin immunofluorescence analysis 
HCT116 cells were grown on coverslips until they were 70% confluent. They were 
washed with PBS (pH 7.4), treated with DP41 at 50 μM and with DMSO as solvent 
control. After incubation for various time periods, cells were washed with PBS, fixed 
in 3% (v/v) formaldehyde in PBS at room temperature for 20 min and permeabilized 
on ice for 5 min with 0.2% (v/v) Triton X-100. This was followed by another washing 
step with PBS, blocking with 2% (w/v) bovine serum albumin (BSA) for 3 × 10 min 
at room temperature on a shaker. Cells were then incubated with a primary antibody 
against α-tubulin for 30 min at 37 °C in a humidified chamber. They were further 
washed with PBS for 3 × 10 min, incubated with secondary antibody 
(ALEXA-Fluor™ 488) at 37 °C for 30 min in the dark, then washed under the same 
conditions as above. This was followed by another treatment with 0.5 μM 
4′,6-diamidino-2-phenylindole (DAPI) at 37 °C for 15 min in a humidified chamber 
and another washing step with PBS on a shaker. Cells on the coverslips were fixed 
with a drop of mounting medium and were analyzed using the QLC-100 microscope 
equipped with a 60 × oil immersion objective (NA 1.4; Nikon, Japan). 
2.2.3.4. Cell cycle analysis 
HCT116 cells (5 × 10
5
) were seeded on a 10 cm Petri dish and grown overnight. The 
medium was changed and cells were treated with DMSO (solvent control) or 50 μM 
DP41 and incubated for 24 h. Media and trypsinized cells were subsequently collected 
from a Petri dish, and centrifuged with 200 ×g at 4 °C for 7 min. Cells were washed 
with cold PBS then centrifuged under the same conditions as above twice before 
being re-suspended in PBS and fixed with 70% ethanol. The cells were incubated 
further with 1 mg/ml RNase (Sigma-Aldrich, Taufkirchen, Germany) and 400 μM 
propidium iodide (1 mg/ml, Sigma-Aldrich) to label DNA. Cells were then analyzed 
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in a flow cytometer (FACSCalibur, 4CS E4021, Becton and Dickinson, Heidelberg, 
Germany). 10,000 events were counted for each sample. Data were analyzed using 
FlowJo software (FlowJo, USA). 
2.2.3.5. Analysis of apoptosis 
HCT116 cells or ARPE-19 cells (5 × 10
5
) were seeded and grown on a 10 cm Petri 
dish overnight. The medium was changed and cells were treated with 50 μM DP41 
and incubated for 24 h. Cells were trypsinized and collected along with media from 
the Petri dish, then centrifuged with 200 ×g at 4 °C for 7 min. Cells were washed with 
binding buffer (BioLegend, Fell, Germany), centrifuged twice and then resuspended 
in 100 μl binding buffer. They were stained with 5 μl annexin V FITC (BioLegend) 
and 10 μl of 0.1 mg/ml propidium iodide (1 mg/ml, Sigma-Aldrich). Cells were then 
analyzed in a cytofluorimeter (FACSCalibur, 4CS E4021, Becton and Dickinson). 
10,000 events were counted for each sample. The data were analyzed using FlowJo 
software (FlowJo). 
2.2.3.6. ROS assay 
HCT116 or ARPE cells (2 × 10
4
) were seeded in 96 black/transparent wells from 
Becton and Dickinson overnight. Medium was removed and cells were washed 3 
times with Tyrode's buffer (10 mM HEPES, 140 mM NaCl, 5 mM KCl, 10 mM 
glucose, 1.8 mM CaCl2, 1 mM MgCl2, pH 7.4) for 3 times. For ROS staining, 3.2 mg 
dihydroethidium (DHE, Sigma-Aldrich) was dissolved in 100 μl DMSO as stock 
solution, and diluted with Tyrode's buffer to 25 μM as working solution. 100 μl 
DHE-working solution was added to each well. After cells were incubated with DHE 
for 30 min at 37 °C in the dark, they were washed again 3 times with Tyrode's buffer. 
100 μl Tyrode's buffer containing 50 mM DP31 or DP41 was then added directly into 
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each well. The fluorescence (Ex/Em: 518 ± 9/606 ± 20 nm) per each well was 
measured with a plate reader (Tecan Infinite M200, Crailsheim, Germany) every 
5 min to determine the concentration of O2˙
−
 inside the cells. 
2.2.3.7. Extraction of cellular proteins 
Following incubation of HCT116 cells or ARPE-19 cells with the test compounds, 
cells were collected in cold PBS, pH 7.4 and centrifuged together with the cell culture 
medium at 4 °C and 250 ×g for 7 min. After one washing step with cold PBS, cells 
were lysed with 100 μl of RIPA buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.5% 
sodium desoxycholate, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS)) 
supplemented with the protease inhibitor cocktail Complete™ according to 
manufacturer's instructions (Roche Diagnostics, Mannheim, Germany). The cell 
lysate was left on ice for 15 min, subjected to sonification (3 × 1 min) at 4 °C and 
then cell debris was removed by centrifugation at 16,250 ×g at 4 °C for 30 min. The 
protein content of the supernatant was determined according to the Bradford method 
using the Bio-Rad protein assay reagent (Bio-Rad, Munich, Germany). 
2.2.3.8. SDS polyacrylamide gel electrophoresis and Western blot analysis 
Proteins were separated on either a 10 or 12.5% sodium dodecyl 
sulfate-polyacrylamide gel and transferred onto a polyvinylidene difluoride membrane 
(PVDF) by tank blotting using a transfer buffer containing 20 mM Tris–HCl, pH 8.8 
and 150 mM glycine. The membrane was blocked with 5% dry milk in PBS 
containing 0.1% Tween-20 for 1 h at room temperature and then incubated with the 
specific antibody which was diluted in PBS with 0.1% Tween-20 containing 1% dry 
milk powder. The membrane was washed with PBS Tween-20 containing 1% 
skimmed milk (3 × 10 min), before being incubated with a peroxidase-coupled 
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secondary antibody (anti-rabbit 1:30,000 or anti-mouse 1:10,000) for 1 h at room 
temperature. The membrane was washed again in PBS Tween-20 (3 × 10 min). 
Signals were developed and visualized by the Lumilight system from Roche 
Diagnostic (Mannheim, Germany). 
2.2.3.9. Treatment with antioxidant 
In order to estimate antioxidant effects on the cellular process triggered by the 
organotellurium compound DP41, and hence, to establish a possible redox-link 
between this compound and its biological activity, HCT116 cells were pretreated with 
100 μM ascorbic acid for 0.5 h and then washed with PBS twice prior to treatment 
with the organochalcogen compounds as described above. 
2.2.3.10. Statistics 
GraphPad Prism software (GraphPad Inc., USA) was used for statistical analysis. 
Results were expressed as arithmetic mean ± s.d. Differences between the 
experimental groups were analyzed using one-way ANOVA or Student's t-test 
(two-tail, unpaired), and statistical significance differences were shown as follows: 
p<0.05 (*), p <0.01 (**) or p < 0.001 (***). 
2.2.4. Results 
2.2.4.1. DP41 induces O2˙− radical formation 
Organoselenium and organotellurium compounds have been known for quite some 
time and their biological functions were tested in fungi, bacteria and some 
mammalian cells. One of the main disadvantages of many of these molecules, 
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however, is the poor solubility in water while others, such as inorganic tellurium salts 
are poorly bioavailable. To circumvent these problems, novel amphiphilic selenium- 
and tellurium-containing compounds have been synthesized and initially characterized 
biophysically [18]. Here, we attempted to analyze two of these compounds, one 
selenium compound (DP31) and the corresponding tellurium compound (DP41) in 
mammalian cells. The structure of these two compounds is shown in Fig. 1. Since 
both, selenium as well as tellurium can act as redox modulators, we first asked 
whether treatment of the human cancer cell line HCT116 might induce the formation 
of O2˙
−
 radicals. We analyzed the generation of O2˙
−
 radicals with a dihydroethidium 
(DHE) assay according to the manufacturer's instructions. As shown in Fig. 2A, 
treatment of HCT116 cells with the selenium compound DP31 did not result in an 
increase in O2˙
−
 radical formation, whereas, the tellurium compound DP41 clearly 
induced the formation of O2˙
−
 radicals. As a control, cells were incubated with the 
solvent dimethyl sulfoxide (DMSO) alone and with H2O2 as a positive control. In 
order to confirm these results, we repeated the experiment with the active compound 
DP41 in the presence of the antioxidant ascorbic acid. As shown in Fig. 2B, ascorbic 
acid led to a down-regulation of the O2˙
−
 radicals after treatment of the cells with 
DP41. Thus, in contrast to the selenium compound the tellurium compound induces 
the formation of reactive oxygen species. 
 
Fig 1. Chemical structures of selenium- and tellurium-containing compounds, 
DP31 and DP41, respectively. 
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Fig 2. DP41 induces generation of O2˙
−
. (A) Relative increases in DHE 
oxidation in HCT116 cells, indicative of O2˙
−
 radical formation following 
treatment with DMSO (solvent control), 50 μM DP31, 50 μM DP41 or 50 μM 
H2O2 for 45 min. (B) Pre-treatment of HCT116 cells with ascorbic acid 
reduces the DP41- or H2O2-induced formation of O2˙
−
. Data are expressed as 
a relative increase in DHE oxidation in relation to solvent control and 
depicted as means ± s.d. (n = 3). **p<0.01 or *p<0.05. 
2.2.4.2. DP41 up-regulates the antioxidant response proteins Nrf2 and HO-1 
Under normal physiological conditions, cells respond to reactive oxygen species 
(ROS) with enzymatic and non-enzymatic defense and signaling mechanisms. One of 
the key players in the antioxidant response in eukaryotic cells is the transcription 
factor nuclear factor erythroid 2-related factor 2 (Nrf2), which is complexed with 
Keap1 in the cytoplasm [19]. ROS induces the liberation of Nrf2 from Keap1 
repression with a subsequent translocation of Nrf2 into the nucleus where it binds to 
the antioxidant response element (ARE) for transcription of various genes. In order to 
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analyze a possible activation of Nrf2 by DP41, cells were treated with these 
compounds for various periods of time. Afterwards, nuclear extracts were prepared 
and analyzed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis 
followed by Western blot with an Nrf2 specific antibody. As shown in Fig. 3A, there 
was an increase in the nuclear Nrf2 protein starting at 1 h and reaching a maximum at 
2 h after treatment with DP41. After 2 h Nrf2 was still present but at a much lower 
level than before. 
 
Fig 3. DP41 induces Nrf2 and HO-1 protein expressions in HCT116 cells. 
Cells were untreated (0 h) or treated with 50 μM DP41 for the indicated 
period of time. Cell lysates were prepared and analyzed on a 10% (A) or a 
12.5% (B) SDS-polyacrylamide gel followed by Western blotting using an 
anti-Nrf2 (A) or an anti-HO-1 (B) specific antibody. α-Tubulin was used as a 
loading control. One representative of at least 2 Western blots is shown here. 
One of the down-stream targets of Nrf2 is the heme oxygenase 1 (HO-1) gene whose 
gene product is a sensitive and reliable indicator of cellular stress [20]. Therefore, in 
the next step, we were interested in evaluating the effect of DP41 on the HO-1 protein 
levels following treatment of HCT116 cells. As shown in Fig. 3B, there was a steady 
increase in HO-1 levels after 2 h of treatment of HCT116 cells with DP41. Thus, from 
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these results it is clear that treatment of HCT116 cells with the tellurium compound 
DP41 resulted in the formation of O2˙
−
 radicals, which is followed by an antioxidant 
response including Nrf2 and HO-1 activation. 
2.2.4.3. DP41 induces other ER stress proteins but not CHOP 
It is well established that O2˙
−
 radicals cause an endoplasmic reticulum (ER) stress 
response [21]. In ER stress response signaling, phosphorylation of the eukaryotic 
initiation factor 2α (eIF2α) is one of the early events. This specific phosphorylation is 
a signal for the attenuation of protein synthesis in ER stressed cells. In order to 
analyze whether treatment of HCT116 cells with the tellurium compound DP41 might 
induce this particular kind of ER stress signaling, cells were treated with DP41 for 
various time intervals. Cells were subsequently lysed and the cell extract analyzed on 
an SDS polyacrylamide gel followed by a Western blot with antibodies against total 
eIF2α or the phosphorylated form of eIF2α. As shown in Fig. 4A, the overall amount 
of eIF2α in the cells remained constant over the time period analyzed. In contrast, we 
noticed a transient increase in the level of phosphorylated eIF2α, commencing after 
1 h of treatment of HCT116 cells with DP41 and remaining at an elevated level for up 
to 6 h after treatment. 
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Fig 4. DP41 induces the expression of proteins related to ER stress in 
HCT116 cells. Cells were untreated (0 h) or treated with 50 μM DP41 for the 
indicated period of time. For phospho-eIF2α and ATF4 positive controls, 
HCT116 cells were treated with 1 μM thapsigargin (TG) for 4 h. Cell lysates 
were prepared and analyzed on a 12.5% SDS-polyacrylamide gel followed by 
Western blotting using anti-p-eIF2 or anti-eIF2α (A), anti-ATF4 (B) or 
anti-CHOP (C) specific antibody. α-Tubulin was used as a loading control. 
One representative of at least three Western blots is shown here. 
Although ER stress signaling leads to a general repression of protein synthesis, it also 
induces the expression of the activating transcription factor 4 (ATF4). ATF4 is a 
transcription activator of genes which are involved in protein folding and assembly, 
metabolism and antioxidation [22]. Therefore, in the next step, we analyzed the 
expression of ATF4 after treatment of HCT116 cells with DP41. As shown in Fig. 4B, 
we observed an increase in the level of ATF4 after 4 h treatment. 
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One of the down-stream targets of ATF4 is the C/EBP homologous protein (CHOP) 
which is also known as growth arrest- and DNA damage-inducible gene 153 
(GADD153) [23-24]. CHOP is considered an inducer of stress mediated apoptosis. 
After incubation of HCT116 cells with DP41 for various periods of time, we lysed the 
cells and the cell extract was subsequently analyzed on an SDS polyacrylamide gel 
followed by a Western blot with a CHOP specific antibody. Fig. 4C shows an increase 
in the level of CHOP 6 h after treatment of HCT116 cells with DP41. The level of 
CHOP remained elevated up to 16 h after treatment. 
2.2.4.4. DP41 causes cell cycle arrest in the G2/M-phase of the cell cycle and 
apoptosis 
Ultimately, CHOP induction after treatment of HCT116 cells with DP41 may result in 
cell cycle arrest and/or apoptosis. Therefore, in the next step, we analyzed the cell 
cycle distribution after treatment of HCT116 cells with DP41 using flow cytometry. 
After treatment of the cells for 24 h, we observed a G2-arrest (Fig. 5). In addition to 
the G2-arrest, we also observed an increase in the number of cells in the subG1-phase, 
which might indicate the beginning of apoptosis. In order to confirm a possible 
induction of apoptosis, we analyzed HCT116 cells with annexin V and propidium 
iodide staining (Fig. 6A). Quantification of apoptotic cells revealed that 24 h after 
treatment, around 20% of the cells were already present in the apoptotic fraction 
(Fig. 6B). To further confirm induction of apoptosis, we analyzed the expression of 
the anti-apoptotic bcl-2 protein. Here, cells were treated with DP41 or with DMSO 
(solvent control) alone for 24 h or 48 h. Cell extracts were analyzed on a SDS 
polyacrylamide gel followed by Western blot with a bcl-2 specific antibody. As 
shown in Fig. 6C, there was a significant down-regulation of bcl-2 after 24 h which 
became even more pronounced after 48 h treatment of HCT116 cells with DP41. In 
the next step, we analyzed the release of cytochrome c from mitochondria into the 
Result and Discussion 
 
93 
 
cytosol as an additional marker of the apoptotic process. Cells were treated as 
described above and cytosolic extracts were analyzed on an SDS-polyacrylamide gel 
followed by Western blot with a cytochrome c specific antibody. Fig. 6D shows an 
increase of cytosolic cytochrome c after treatment of the cells with DP41, whereas 
there was no such increase in DMSO treated control cells. Next, we analyzed the cells 
for caspase 3 cleavage as an even further proof for apoptosis. Cells were treated as 
described earlier and caspase 3 cleavage was analyzed with a caspase 3 specific 
antibody. The caspase 3 cleavage product was detected in DP41 treated cells but not 
in the control cells treated with DMSO alone (Fig. 6E). To further confirm this result, 
we looked for the cleavage of poly-ADP-ribose polymerase (PARP), which is a well 
known substrate for caspase 3/7. We again treated HCT116 cells with DP41 for 24 h 
or for 48 h. Cells were lysed and the cell extract was analyzed on an SDS 
polyacrylamide gel followed by Western blot with a PARP specific antibody. As 
shown in Fig. 6F, after 24 h and 48 h of treatment, there was a band for the PARP 
cleavage product. Thus, all these results show that treatment of HCT116 cells with 
DP41 results in a G2-arrest of the cell cycle, and the induction of apoptosis. 
 
Fig 5. Influence of DP41 on cell cycle distribution. HCT116 cells were treated 
for 24 h with DMSO (solvent control) or 50 μM DP41 and then analyzed by 
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FACS. Cytofluorimetric analysis of treated cells. One representative of at least 
three independent experiments is shown here. 
 
 
Fig 6. DP41 induces apoptosis in HCT116 cells by modulating bcl-2 protein 
expression, inducing cytochrome c release and activation of both, caspase 3 
and PARP cleavage. (A) Cells were treated for 24 h with either DMSO 
(solvent control) or 50 μM DP41 and then stained with annexin-V and 
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propidium iodide (PI) before being analyzed by FACS for apoptotic cell death. 
Viable cells are presented as both annexin-V and PI negative. (B) Percentage 
distribution of DP41-induced apoptotic cell death relative to DMSO control. 
One representative of at least three independent experiments is shown here. 
Means ± s.d. (n = 3). **p < 0.01 or *p < 0.05. (C–F) HCT116 cells were 
treated with either DMSO or 50 μM DP41 for 24 and 48 h, and protein 
expressions, PARP cleavage and caspase 3/7 activation and cleavage were 
subsequently studied and analyzed by Western blot. Proteins were separated 
on a 12.5% SDS-polyacrylamide gel and blotted on a PVDF membrane. Bcl-2 
(C), cytochrome c (D) or PARP cleavage (F) was visualized with the 
appropriate antibody, while full-length caspase 3/7 and its cleavage products 
(E) were detected with a caspase 3-specific antibody (8G10). α-Tubulin was 
used as a loading control. One representative of at least three Western blots is 
shown here. 
Based on the finding that DP41 arrested HCT116 cells in the G2-phase of the cell 
cycle, we next examined the effect of DP41 on the microtubule organization by 
immunostaining of α-tubulin. A normal microtubule distribution in HCT116 cells and 
network formation were observed in the cytoplasm of HCT116 cells treated with 
DMSO alone. In sharp contrast, taxol as a positive control caused a disruption of the 
microtubule network and a very similar result was obtained with DP41 (Fig. 7). Thus, 
DP41 destroys the microtubulin network in HCT116 cells. 
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Fig 7. Treatment of HCT116 cells with DP41 affects the organization of the 
cells' microtubule network. HCT116 cells were cultured overnight before 
incubation with DMSO (solvent control), 50 μM DP41 or 50 μM taxol 
(positive control) for 24 h. Cells were fixed with formaldehyde before being 
incubated with monoclonal anti-α-tubulin for 30 min at 37 °C followed by 
30 min incubation at 37 °C with the ALEXA-Fluor™ 488 secondary antibody. 
After three washing steps, the cells were briefly stained with DAPI. The 
organization of the microtubule network (green) and nucleus (blue) was 
visualized with a Zeiss Axioskop fluorescence microscope. 
All experiments described so far were performed with the cancer cell line HCT116. In 
order to evaluate whether the effects seen with DP41 are restricted to such cancer 
cells, we analyzed the effect of DP41 on normal retinal epithelium ARPE-19 cells. 
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ARPE-19 cells were treated with DP41 and cells were analyzed for ROS production 
as described above for HCT116 cells. The results are shown in Fig. 8A. In the control 
experiment with H2O2, we found a clear induction of ROS production, whereas, with 
the tellurium compound DP41, ROS induction was notably absent in these cells. Since 
there is no notable increase in ROS levels in normal cells, we wonder whether normal 
cells would also avoid apoptosis under these conditions. Apoptosis was analyzed by 
annexin V and propidium iodide staining after treatment of ARPE-19 cells with DP41 
for 48 h. Fig. 8B and the statistical analysis presented in Fig. 8C reveal no induction 
of apoptosis in ARPE-19 cells. In order to support these findings by another method, 
we treated ARPE-19 cells with DP41. As a positive control, HCT116 cells were 
treated with 5-fluorouracil (5-FU). The cell extract was analyzed on an 
SDS-polyacrylamide gel followed by Western blot with an anti-PARP antibody. As 
shown in Fig. 8D, there was a clear signal for the PARP cleavage product at a 
molecular weight of 89 kDa in 5-FU treated cells, whereas, no such signal was 
observed in DMSO or DP41 treated cells. Thus, these results demonstrate that in 
contrast to HCT116 cells, ARPE-19 cells are resistant against apoptosis after 
treatment with DP41. 
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Fig. 8. Impact of DP41 on non-cancerous ARPE-19 cells. (A) DHE oxidation in 
ARPE-19 cells, indicative of O2˙
−
 radical formation as a result of treatment with 0.05% 
DP41
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DMSO, 50 μM DP41 or 50 μM H2O2 for 45 min. Data are expressed as a fold 
increase in DHE oxidation rate in relation to solvent control and are depicted as 
means ± s.d. (n = 3). *p < 0.05, **p < 0.01 or ***p < 0.001. (B) Cells were treated 
for 24 h with either DMSO or 50 μM DP41 and then stained with annexin-V and 
propidium iodide (PI) before being analyzed by FACS for apoptotic cell death. Viable 
cells are presented as both annexin V and PI negative. (C) Percentage distribution of 
DP41-induced apoptotic cells relative to DMSO control. One representative of at 
least three similar independent experiments is shown here. Means ± s.d. (n = 3). 
*p < 0.05, **p < 0.01 or ***p < 0.001. (D) ARPE-19 cells were either left untreated, 
treated with 0.05% DMSO or treated with 50 μM DP41 for 24 and 48 h. As a positive 
reference, HCT116 cells were treated with 50 μg/μl 5-fluorouracil (5-FU) for 24 h 
and PARP cleavage was then studied by Western blotting. Cells were untreated (0 h) 
or treated with 50 μM DP41 for the indicated period of time. For a positive control, 
LNCaP cells were treated with 2 μg/ml tunicamycin (TM) for 24 h. Cell lysates were 
prepared and analyzed on a 12.5% SDS-polyacrylamide gel followed by Western 
blotting using anti-CHOP specific antibody (E). α-Tubulin was used as a loading 
control in both (D) and (E). One representative of at least three Western blots is 
shown here. 
Since CHOP is a critical factor in ER stress induced apoptosis in cancer cells 
(Fig. 4C), we next analyzed ARPE-19 cells for CHOP induction after DP41 treatment. 
Cell extracts were analyzed on an SDS-polyacrylamide gel followed by Western blot 
with a CHOP specific antibody. As shown in Fig. 8E, we could not detect the 
expression of CHOP in DP41 treated ARPE-19 cells, whereas, in the positive control, 
there was a clear signal for the CHOP protein. 
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2.2.5. Discussion 
The unique redox and catalytic properties of organoselenium and organotellurium 
compounds turn these compounds into attractive molecules for pharmaceutical studies. 
Previously, two major drawbacks of these compounds included the poor water 
solubility on the one hand and the limited penetration of the compounds through 
membranes into the cells on the other hand. These drawbacks were mainly solved by 
the recently published synthesis of amphiphilic organoselenium and organotellurium 
compounds with an anionic head group and different hydrophobic tail lengths 
[13] and [18]. In these studies, it turned out that the selenium compounds were less 
cytotoxic than the corresponding tellurium compounds. Yet at the time, the 
intracellular process responsible for this activity remained mostly speculative. We, 
therefore, selected the most active tellurium compound DP41 to study its influence on 
some of the most relevant cellular signaling events. We found that the 
organotellurium compound DP41 induced the production of reactive oxygen species 
O2˙
−
, which was prevented by the simultaneous application of ascorbic acid. In 
contrast, the corresponding organoselenium compound DP31 failed to induce O2˙
−
 
radical production. Thus, the organotellurium compound DP41 is more redox active 
in cancer cells than in the corresponding organoselenium compound DP31, which 
supports previous findings [18]. Based on these results, we decided to analyze the 
cellular signaling pathways, which are triggered by DP41. Due to the fact that DP41 
induced the production of reactive oxygen species, it was not surprising that DP41 
also activated the Keap1–Nrf2 pathway, which is the major regulator of the 
cytoprotective response to endogenous and exogenous stresses caused by ROS and 
electrophiles [25]. Nrf2 is a transcription factor that binds to the antioxidant response 
element (ARE) in the regulatory regions of target genes. One of the Nrf2 target genes 
is heme oxygenase1 (HO-1), whose protein was here found to be up-regulated as well 
after treatment of HCT116 cells with DP41. Gene transcription of HO-1 is inducible 
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by a broad spectrum of stimuli. Such agents include a large number of 
pharmacological agents as well as heat shock and other forms of extracellular and 
intracellular stresses [26]. A number of studies have demonstrated that HO-1 can 
confer protective i.e. anti-apoptotic and anti-proliferative effects on various cellular 
systems, where the underlying mechanisms, however, have not been completely 
elucidated. Yet, interestingly, the ER stress signaling pathway can also activate an 
antioxidant program by preferentially inducing the expression of the mRNA encoding 
ATF4 and by phosphorylation of Nrf2 [27]. Furthermore, Nrf2 activation has been 
implicated in the promotion of cell survival following ER stress [28]. Interestingly, 
we also observed an induction of the ER signaling pathway by an elevated level of 
phosphorylated eIF2α and an elevated level of ATF4 which is followed by an 
activation of CHOP. In mice liver, it has been shown that CHOP expression in Nrf2 
deficient cells is constitutively higher than in wild-type cells, whereas, Nrf2 
over-expression attenuates CHOP accumulation during ER stress [29]. It is also 
known that the ATF4 gene product binds to the amino acid response element (AARE) 
in the CHOP promoter after severe ER stress and activates CHOP transcription. 
Induction of CHOP is reported to be essential for the apoptotic response after 
extended ER stress [30]. According to our present results, HCT116 cells start to go 
into apoptosis after treatment with DP41. Thus, ER stress induced by DP41 on the one 
hand seems to be so severe that the antioxidant mechanism leading to a HO-1 
mediated down-regulation of CHOP resulting in cell survival fails in the cells, while 
the pro-apoptotic ER stress signaling via p-eIF2α/ATF4 and CHOP activation 
dominates leading to apoptosis on the other hand. 
All of the experiments discussed above were performed with HCT116 colon 
carcinoma cells. It was therefore a very interesting observation that normal ARPE-19 
cells did not respond with an increase in the level of O2˙
−
 radicals and also did not 
induce apoptosis when subjected to DP41 under the same experimental conditions as 
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with HCT116 cells. Thus, we conclude that normal cells are more resistant to the 
organotellurium compound DP41 compared to cancer cells. This resistance is 
probably due to the fact that normal cells do not respond with an increased level of 
ROS when treated with DP41, or alternatively, keep such an increase under control, 
for instance by a strong antioxidant response. It has been shown earlier that red blood 
cells were comparably lysed by the organoselenium and by the organotellurium 
compound which seems to be independent from the redox activity of the compound 
and is more likely due to the amphiphilic character of these compounds which is 
similar to that of sodium dodecylsulfate [18]. HCT116 cells and also ARPE-19 cells 
are clearly resistant to this lytic function. The fact that cancer cells go into apoptosis 
and normal cells are apparently resistant to treatment with DP41 might indicate a 
future potential application of this organotellurium compound in cancer therapy. 
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2.3.1. Abstract 
Selenium compounds play a major role in Biology, where they are often associated 
with pronounced antioxidant activity or toxicity. Whilst most selenium compounds 
are not necessarily hazardous, their often selective cytotoxicity is interesting from a 
biochemical and pharmaceutical perspective. We have synthesized a series of 
amphiphilic molecules which combine a hydrophilic seleninic acid head group – 
which at the same time serves as thiol-specific warhead – with a hydrophobic tail. 
These molecules possess a surface activity similar to the one of SDS, yet their 
biological activity seems to exceed by far the one of a simple surfactant (e.g. SDS) or 
seleninic acid (e.g. phenyl seleninic acid). Such compounds effectively haemolyse 
Red Blood Cells and exhibit pronounced activity against Saccharomyces cerevisiae. 
From a chemical perspective, the seleninic warheads are likely to attack crucial 
cysteine proteins of the cellular thiolstat. 
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2.3.2. Introduction 
In Biology, redox active Group 16 compounds are often able to modulate the 
intracellular redox balance of living cells and hence play a major role in biological 
processes, medicine and drug development [1–6]. Nonetheless, such compounds are 
not outrightly hazardous but often possess a certain selectivity. Their inherent 
(cyto-)toxicity may even be used to single out and selectively kill certain target cells. 
For instance, naturally occurring sulfur-based pro-oxidants, such as allicin from garlic, 
effectively kill various microorganisms and also attack cancer cells fairly selectively. 
Certain selenium and tellurium compounds are also effective against a range of cancer 
cells in cell culture, animal models and in patient-derived materials, although this kind 
of selective cytotoxicity is not yet fully understood [5–9]. The circumstance that such 
chalcogen-based agents are effective, yet also selective cytotoxic agents is probably 
the result of the specific reactivity of these agents towards the thiol groups found in 
cysteine-containing proteins. The latter become oxidized in the process and hence 
trigger an appropriate pro-apoptotic signal [10-12]. Indeed, a selective attack on the 
intracellular ‘thiolstat’ with subsequent apoptosis of cells with an impaired 
intracellular redox balance, such as diverse cancer cells, holds considerable promise, 
as normal cells seem to be less affected [10-13]. 
The last decade has therefore witnessed a growing interest in redox modulation and 
novel redox modulating substances, with many selenium agents at the forefront of 
these developments [14]. Selenium compounds generally are more reactive and hence 
active than their sulfur analogues, yet are less hazardous and toxic than the tellurium 
ones. Nonetheless, selenium compounds cannot be employed in biological systems 
easily due to often unfavourable physico-chemical properties, low bioavailability and 
the fact that such compounds tend to act ‘alone’, as single molecules. 
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We have therefore synthesized a novel class of bifunctional agents comprised of a 
biologically active seleninic acid moiety embedded in an overall amphiphilic structure. 
The latter should endow such compounds with additional properties, such as good 
solubility and permeability through membranes, and hence improve handling and 
biological activity (Fig. 1). Furthermore, such molecules can aggregate (e.g. in form 
of micelles) or attach to membranes and proteins, and hence may show synergistic or 
collective (re-)activities when compared to their monomeric forms. Such synergy has 
been seen already in the case of sulfur, selenium and tellurium nanoparticles [15-17]. 
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Fig 1. Design and reactivity of amphiphilic seleninic acids which combine 
redox modulating properties with the ability to form aggregates (e.g. micelles), 
and to interact with membranes and (hydrophobic parts) of proteins. Some of 
the expected biological activities are highlighted. 
Whilst some amphiphilic selenium-containing agents have been reported before, such 
compounds had to rely on complex ‘head’ and ‘tail’ groups or on co-micellation 
[6] and [17]. In order to address this apparent lack of suitable molecules available, we 
have recently reported the synthesis and biological activity of a series of selenium- 
and tellurium-containing surfactants based on a hydrophilic sulfate head group [18]. 
The synthetic approach used by us at the time (i.e. a multi-step synthesis including an 
aggressive O-sulfation step) has been rather cumbersome, however, and marred by 
overall low yields, and difficulties to apply it to a wider range of structures. 
Importantly, O-sulfation has been achieved with the use of chlorosulfonic acid, and 
this final step required to introduce the hydrophilic head group can lead to an overall 
damage and subsequent instability of the molecule in question (including hydrolysis 
of the sulfate head group). Indeed, the use of common hydrophilic head groups, such 
as a sulfate, phosphate or ammonium group, poses certain challenges as far as their 
introduction and subsequent chemical stability are concerned (carboxylic acids are 
easier to use but often of insufficient hydrophilicity) [19-22]. 
As part of this study, we have therefore explored the use of a seleninic acid as ‘head’ 
group as elegant alternative to conventional approaches, hence removing the need for 
a separate hydrophilic head and, at the same time, endowing the head with 
considerable (thiol-)specific chemical reactivity (Fig. 1). Indeed, while seleninic acids 
have mostly been ignored in biological selenium chemistry in the past, they represent 
the ultimate thiol-specific cysteine-modifying agent which reacts with and hence 
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modifies several thiol groups and also turns catalytic once it reaches the selenylsulfide 
(RSeSR’) or selenol (RSeH) oxidation state (Fig. 1) [23-25]. 
 
2.3.3. Experimental 
2.3.3.1. General methods for synthetic chemistry 
All starting materials and solvents used were purchased from Acros Organic (Geel, 
Belgium), Alfa Aesar (Karlsruhe, Germany) or Sigma Aldrich (Steinheim, Germany) 
as reagent grade and were used without further purification. Melting points were 
determined with a ThermoFisher apparatus and are uncorrected. NMR spectra were 
recorded with a Bruker AC 250 MHz spectrometer for 
1
H and 
13
C. 
77
Se spectra were 
measured with a Bruker Avance 500 with 500 MHz in CDCl3 or DMSO-d6. All 
chemical shifts are reported in parts per million (ppm). MS spectra were recorded on 
an Agilent Technologies GC-MS instrument equipped with a 7683 injector, 6890 N 
gas chromatograph and a 5973 mass selective detector. The mass spectrometer was 
operated in EI mode at 70 eV, and MS spectra were recorded from m/z 50 to 650. All 
reactions were routinely checked by thin layer chromatography (TLC) analysis on an 
Alugram SIL G/UV254 plate (Macherey-Nagel) with spots visualized by UV light. 
2.3.3.2. Synthesis of 4-selenocyanatobenzenamine 
4-Selenocyanatobenzenamine was synthesized via a known procedure, according to 
Kachanov et al. and Plano et al. [26] and [27]. Briefly, selenium dioxide (36 mmol) 
was added to a solution of malononitrile (13 mmol) in DMSO (15 ml) at 0 °C. The 
mixture was stirred at 0 °C for 30 min and the colour of the mixture subsequently 
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changed to dark red. Then, the reaction mixture was poured into 100 ml of cold water 
and the colour of the mixture instantaneously changed from red to yellow. The 
resulting precipitate was filtered and dried overnight. Then 2.5 g of the residue was 
suspended in 20 ml DMSO and aniline (18 mmol) was added. The mixture was stirred 
for 60 min at room temperature. After this time the reaction mixture was poured into 
water (150 ml) with stirring. The precipitate was filtered, washed with water and dried 
at room temperature overnight. The isolated solid was purified by recrystallization in 
isopropanol. 
2.3.3.2.1. 4-Selenocyanatobenzenamine 
Yield: 59%; colourless solid; mp 88 °C; 
1
H NMR (250 MHz, CDCl3) δ 7.32–7.35 (m, 
2H, benzene protons), 6.55–6.58 (m, 2H, benzene protons), 5.65 (bs, 2H, J = 6.5 Hz, 
–NH2) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 150.62, 136.35 (2C), 114.97 (2C), 
105.35, 105.03 ppm; HRMS (ESI) [M + H]
+
 C7H7N2Se calc. 198.9762, found 
198.9769. 
2.3.3.2.2. General procedure for the synthesis of 
N-(4-selenocyanatophenyl)-alkylamide 
The appropriate alkyl acid chloride (2 mmol) was added to a solution of 
4-selenocyanatobenzenamine (2.2 mmol) in 50 ml of pyridine, the mixture was stirred 
at 110 °C for 1 h. After this time 30 ml of cold water was added, the reaction mixture 
was neutralized by 5 M HCl. The solution was extracted with ethyl acetate 
(3 × 40 ml), the organic layers were separated and washed with 5 M HCl (3 × 30 ml), 
and subsequently dried with MgSO4. The solvent was removed under vacuum and the 
residue was washed with petrol ether (3 × 20 ml), and dried at room temperature 
overnight. 
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2.3.3.2.2.1. N-(4-selenocyanatophenyl)octanamide 
Yield: 96%; colourless solid; mp 101 °C; 
1
H NMR (250 MHz, CDCl3) δ 10.08 (bs, 
1H, –NHCO–) 7.63 (s, 4H, benzene protons), 2.27–2.33 (t, 2H, J = 7.5 Hz, 
–CH2CO–), 1.56 (m, 2H, –CH2CH3), 1.24–1.26 (s, 8H, –(CH2)4CH2CH3), 0.82–0.83 
(m, 3H, –CH3) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 171.68, 139.95, 134.69 (2C), 
121.10 (2C), 115.07, 101.72, 37.78, 31.63, 29.16, 28.98, 25.42, 22.58, 14.03 ppm; 
77
Se NMR (92.5 MHz, CDCl3, dimethylselenide as reference δ 313.13 ppm); HRMS 
(ESI) [M + H]
+
 C15H21N2OSe calcd. 325.0807, found 325.0814. 
2.3.3.2.2.2. N-(4-selenocyanatophenyl)decanamide 
Yield: 99%; colourless solid; mp 102 °C; 
1
H NMR (250 MHz, CDCl3) δ 7.61 (s, 4H, 
benzene protons), 7.22 (bs, 1H, –NHCO–) 2.35–2.41 (t, 2H, J = 7.5 Hz, –CH2CO–), 
1.70–1.76 (m, 2H, –CH2CH3), 1.27–1.33 (m, 12H, –(CH2)6CH2CH3), 0.85–0.90 (m, 
3H, –CH3) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 171.65, 139.93, 134.69 (2C), 121.08 
(2C), 115.07, 101.70, 37.80, 31.83, 29.40, 29.33, 29.24, 29.21, 25.42, 22.64, 
14.08 ppm; 
77
Se NMR (92.5 MHz, CDCl3, dimethylselenide as reference δ 
320.71 ppm); HRMS (ESI) [M + H]
+
 C17H25N2OSe calcd. 353.1125, found 353.1127. 
2.3.3.2.2.3. N-(4-selenocyanatophenyl)dodecanamide 
Yield: 98%; colourless solid; mp 109 °C; 
1
H NMR (250 MHz, CDCl3) δ 7.51 (s, 4H, 
benzene protons), 7.29 (bs, 1H, –NHCO–), 2.34–2.40 (t, 2H, J = 7.5 Hz, –CH2CO–), 
1.63–1.72 (m, 2H, –CH2CH3), 1.22–1.32 (m, 16H, –(CH2)8CH2CH3), 0.85–0.88 (m, 
3H, –CH3) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 171.74, 139.98, 134.69 (2C), 121.11 
(2C), 115.03, 101.77, 37.79, 31.88, 29.58, 29.45, 29.33 (2C), 29.31, 29.22, 25.43, 
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22.66, 14.10 ppm; 
77
Se NMR (92.5 MHz, CDCl3, dimethylselenide as reference δ 
320.63 ppm); HRMS (ESI) [M + H]
+
 C19H29N2OSe calcd. 381.1434, found 381.1440. 
2.3.3.2.2.4. N-(4-selenocyanatophenyl)tetradecanamide 
Yield: 97%; colourless solid; mp 106 °C; 
1
H NMR (250 MHz, CDCl3) δ 7.60 (s, 4H, 
benzene protons), 7.32 (bs, 1H, –NHCO–), 2.34–2.40 (t, 2H, J = 7.5 Hz, –CH2CO–), 
1.69–1.75 (m, 2H, –CH2CH3), 1.25–1.32 (m, 20H, –(CH2)10CH2CH3), 0.85–0.90 (m, 
3H, –CH3) ppm; 
13
C NMR (62.5 MHz, CDCl3) δ 171.69, 139.95, 134.70 (2 C), 
121.08 (2 C), 115.05, 101.75, 37.80, 31.90, 29.66 (2 C), 29.63 (2 C), 29.59, 29.45, 
29.34, 29.22, 25.43, 22.67, 14.11 ppm; 
77
Se NMR (92.5 MHz, CDCl3, 
dimethylselenide as reference δ 320.64 ppm); HRMS (ESI) [M + H]+ C21H33N2OSe 
calcd. 409.1747, found 409.1753. 
2.3.3.2.2.5. N-(4-selenocyanatophenyl)palmitamide 
Yield: 96%; colourless solid; mp 112 °C; 
1
H NMR (250 MHz, CDCl3) δ 7.60 (s, 4H, 
benzene protons), 7.17 (bs, 1H –NHCO–), 2.34–2.40 (t, 2H, J = 7.5 Hz, –CH2CO–), 
1.70–1.76 (m, 2H, –CH2CH3), 1.23–1.34 (m, 24H, –(CH2)12CH2CH3), 0.86–0.91 (m, 
3H, –CH3) ppm; 13C NMR (62.5 MHz, CDCl3) δ 171.64, 139.92, 134.70 (2C), 121.08 
(2C), 115.09, 101.67, 37.81, 31.90, 29.67, 29.65, 29.64 (2C), 29.62 (2C), 29.59, 29.45, 
29.34, 29.22, 25.42, 22.67, 14.10 ppm; 
77
Se NMR (92.5 MHz, CDCl3, 
dimethylselenide as reference δ 320.56 ppm); HRMS [M + H]+ C23H37N2OSe calcd. 
437.2049, found 437.2067. 
2.3.3.2.3. General procedure for the synthesis of 
3-chloro-4-alkylamidobenzeneseleninic acid 
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Sulfuryl chloride (SO2Cl2) (3.3 mmol) was added to a solution of 
N-(4-selenocyanatophenyl)-alkylamide (2 mmol) in 25 ml of chloroform and resulted 
in a yellow precipitate. The mixture was stirred under reflux for 30 min until a clear 
orange solution was formed. After this time the solvent was removed under vacuum. 
Then, 30 ml of cold water was added dropwise to the remaining oily mixture, and the 
resulting reaction mixture was stirred for further 20 min. 30 ml of cold water was 
added to the solution and the reaction mixture was neutralized with 5 M HCl. The 
mixture was washed with ethyl acetate (3 × 30 ml), the organic layers were separated 
and washed with 5 M HCl (3 × 30 ml), and subsequently dried with MgSO4. The 
solvent was removed under vacuum and the residue was washed with petrol ether 
(3 × 20 ml). When the precipitate appeared, it was filtered, washed with ethyl acetate 
(3 × 20 ml), and dried overnight. 
2.3.3.2.3.1. 3-Chloro-4-octanamidobenzeneseleninic acid (1) 
Yield: 96%; colourless solid; mp 134 °C; 
1
H NMR (250 MHz, DMSO-d6) δ 9.95 (bs, 
1H, –NHCO–) 7.87–7.95 (m, 2H, benzene protons), 7.71–7.74 (m, 1H, benzene 
protons), 2.31–2.37 (t, 2H, J = 7.5 Hz, –COCH2–), 1.55–1.58 (m, 2H, –CH2CH3), 
1.25–1.27 (m, 8H,–(CH2)4CH2CH3), 0.82–0.85 (3H, m, –CH3) ppm; 
13
C NMR 
(62.5 MHz, DMSO-d6) δ 171.81, 145.93, 137.74, 126.68, 126.25, 125.81, 125.03, 
35.71, 31.13, 28.48, 28.34, 25.03, 22.00, 13.89 ppm; 
77
Se NMR (92.5 MHz, 
DMSO-d6, dimethylselenide as reference δ 1181.77 ppm); HRMS [M + H]
+
 
C14H21ClNO3Se calcd. 366.0362, found 366.0367. 
2.3.3.2.3.2. 3-Chloro-4-decanamidobenzeneseleninic acid (2) 
Yield: 95%; colourless solid; mp 141 °C; 
1
H NMR (250 MHz, DMSO-d6) δ 9.63 (bs, 
1H, –NHCO–) 7.86–7.95 (m, 2H, benzene protons), 7.70–7.74 (m, 1H, benzene 
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protons), 2.37–2.43 (t, 2H, J = 7.5 Hz, –COCH2–), 1.55–1.61 (m, 2H, –CH2CH3), 
1.23 (s, 12H, –(CH2)6CH2CH3), 0.86–0.81 (m, 3H, –CH3); 
13
C NMR (62.5 MHz, 
DMSO-d6) δ 171.81, 145.90, 137.74, 126.69, 126.25, 125.81, 125.03, 35.71, 31.22, 
28.85, 28.71, 28.61, 28.51, 25.02, 22.04. 13.90 ppm; 
77
Se NMR (92.5 MHz, 
DMSO-d6, dimethylselenide as reference δ 1181.75 ppm); HRMS [M + H]
+
 
C16H25ClNO3Se calcd. 394.0659, found 394.0681. 
2.3.3.2.3.3. 3-Chloro-4-dodecanamidobenzeneseleninic acid (3) 
Yield: 93%; colourless solid; mp 131 °C; 
1
H NMR (250 MHz, DMSO-d6) δ 9.63 (bs, 
1H, –NHCO–) 7.86–7.95 (m, 2H, benzene protons), 7.70–7.74 (m, 1H, benzene 
protons), 2.37–2.43 (t, 2H, J = 7.5 Hz, –COCH2–), 1.55–1.61 (m, 2H, –CH2CH3), 
1.24 (s, 16H, –(CH2)8CH3), 0.81–0.86 (3H, m, –CH3) ppm; 
13
C NMR (62.5 MHz, 
DMSO-d6) δ 171.82, 145.92, 137.73, 126.68, 126.27, 125.83, 125.03, 35.71, 31.23, 
28.95, 28.93, 28.88, 28.70, 28.65, 28.50, 25.02, 22.04, 13.90 ppm; 
77
Se NMR 
(92.5 MHz, DMSO-d6, dimethylselenide as reference δ 1181.77 ppm); HRMS 
[M + H]
+
 C18H29ClNO3Se calcd. 422.1001, found 422.0994. 
2.3.3.2.3.4. 3-Chloro-4-tetradecanamidobenzeneseleninic acid (4) 
Yield: 98%; colourless solid; mp 125 °C; 
1
H NMR (250 MHz, DMSO-d6) δ 9.49 (bs, 
1H, –NHCO–), 7.86–7.97 (m, 2H, benzene protons), 7.71–7.74 (m, 1H, benzene 
protons), 2.37–2.34 (t, 2H, J = 7.5 Hz, –COCH2–), 1.57–1.62 (m, 2H, –CH2CH3), 
1.24 (s, 20H, –(CH2)10CH2CH3), 0.82–0.87 (m, 3H, –CH3) ppm; 
13
C NMR (62.5 MHz, 
DMSO-d6) δ 171.81, 145.92, 137.72, 126.67, 126.25, 125.83, 125.02, 35.70, 31.24, 
29.00, 28.97 (2C), 28.95, 28.88, 28.70, 28.66, 28.51, 25.02, 22.04, 13.91 ppm; 
77
Se 
NMR (92.5 MHz, DMSO-d6, dimethylselenide as reference δ 1181.85 ppm); HRMS 
(ESI) [M + H]
+
 C20H33ClNO3Se calcd. 450.1314, found 450.1307. 
Result and Discussion 
 
117 
 
2.3.3.2.3.5. 3-Chloro-4-palmitamidobenzeneseleninic acid (5) 
Yield: 99%; colourless solid; mp 116 °C; 
1
H NMR (250 MHz, DMSO-d6) δ 9.62 (bs, 
1H, –NHCO–) 7.87–7.95 (m, 2H, benzene protons), 7.71–7.74 (m, 1H, benzene 
protons), 2.37–2.43 (t, 2H, J = 7.5 Hz, –COCH2–), 1.55–1.58 (m, 2H, –CH2CH3), 
1.24 (s, 24H, –(CH2)12CH3), 0.81–0.86 (m, 3H, –CH3) ppm; 
13
C NMR (62.5 MHz, 
DMSO-d6) δ 171.81, 137.14, 126.68, 126.23, 125.79, 125.02, 35.17, 31.24, 28.98 
(2C), 28.95 (2C), 28.88 (2C), 28.70 (2C), 28.65 (2C), 28.51, 25.02, 22.04, 13.89 ppm; 
77
Se NMR (92.5 MHz, DMSO-d6), dimethylselenide as reference δ 1181.19 ppm); 
HRMS (ESI) [M + H]
+
 C22H37ClNO3Se calcd. 478.1614, found 478.1620. 
2.3.3.3. Surface activity and critical micelle concentration (CMC) measurements 
Compounds 1–4 were dissolved in bidistilled water and the final concentrations used 
for this experiment were as follows: 0.025 mM, 0.25 mM, 0.5 mM, 1 mM, 5 mM and 
10 mM. This experiment was carried out with a Krüss Schultensiometer K6 (Krüss 
GmbH, Hamburg) according to the manufacturer's instructions. Each experiment was 
carried out in triplicate, and each experiment was repeated on three separate 
occasions. 
2.3.3.4. Haemolysis assay and Ca2+-uptake assay 
A standard method described in the literature was used for this experiment with some 
modifications [28-32]. Final concentrations of the compounds tested were: 1 μM, 
10 μM, 100 μM and 1000 μM for haemolysis assay, and 3 μM for Ca2+-uptake assay. 
RBCs were incubated with compounds tested for 10 min, and then analysed by FACS 
(FACSCalibur 4CS E4021, Becton and Dickinson and CellQuest software). Each 
experiment was carried out in triplicate, and each experiment was repeated on three 
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separate occasions. 1% DMSO was used as negative control. In the haemolysis assay, 
SDS was used as positive control. In the Ca
2+
-uptake assay, the well-known calcium 
ionophore A23187 (abbreviated as A23) was used as positive control. 
2.3.3.5. Antifungal activity assay 
The inhibitory activity on the growth rate of Saccharomyces cerevisiae of compounds 
tested was evaluated based on the CLSI (formerly NCCLS) guidelines outlined in the 
M27-A2 protocol with modifications [33]. Absorbance changes were monitored 
continuously on a spectrophotometer (595 nm) (CARY 50Bio UV-Visible 
spectrophotometer, Varian Inc.) against the blank – DMSO (0.5%) in YPD broth – 
during the time until reaching the stationary phase over a period of 24 h. S. cerevisiae 
was exposed to compounds tested at the concentrations between 1 μM and 1 mM (all 
in 0.5% DMSO). DMSO (0.5%) and miconazole (100 μM) were used as the negative 
and positive controls, respectively. 
2.3.4. Results 
In order to investigate seleninic acid based-amphiphilic molecules, we have 
developed a new synthetic strategy to synthesize five new seleninic acids, whose 
surface activity and ability to lyse red blood cells (RBCs) has been determined. These 
interactions translate into a significant antimicrobial activity, as illustrated for 
Saccharomyces cerevisiae. This pronounced biological activity appears to be the 
result of a synergism between the reactivity of the seleninic acid and amphiphilicity of 
the molecule, hence exceeding the ‘singular’ activities associated with a simple 
surfactant or a simple seleninic acid. 
2.3.4.1. Chemical synthesis of new seleninic acids 
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As seleninic acids are often fairly reactive and hence unstable (e.g. in the presence of 
nucleophiles such as thiols, selenols), the synthesis of appropriate derivatives is not 
always straight forward and requires specific considerations, especially when 
planning the reaction sequence and attempting to diversify the structures. We have, 
for instance, been unable to generate the seleninic acid forms of our compounds via 
the ‘classic’ synthetic avenue often used for simple seleninic acids, i.e. by oxidation 
of diselenides with hydrogen peroxide. Furthermore, selenium chemistry also 
demands certain experimental skills. To overcome these obstacles, we have developed 
a simple, yet effective approach for the synthesis of suitable amphiphilic derivatives 
based on the initial synthesis of a key amine-derivative of phenyl selenocyanate, 
which allows subsequent coupling of various hydrophobic tails and final oxidation of 
the resulting selenocyanates to seleninic acids ( Fig. 2) [34]. This method intentionally 
keeps the seleninic acid ‘under wrap’ until the very last step of the synthesis, and 
hence provides considerable flexibility earlier on in the reaction sequence, for 
instance when it comes to the use of functional groups and reagents. Interestingly, it 
also adds an additional chlorine substituent to the phenyl ring which may be modified 
further later on. This method has enabled us to synthesize different seleninic acids 
with comparable ease and in overall yields of around 55%. 
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Fig 2. Synthesis of amphiphilic seleninic acids by initial synthesis of 
4-selenocyanatobenzenamine and subsequent coupling of a hydrophobic tail and 
oxidation of the selenocyanate to seleninic acid. 
 
2.3.4.2. Surface activity in the context of self-assembly and interactions with cell 
membranes 
One of the key properties associated with the new seleninic acids – besides their redox 
activity – is their expected amphiphilicity, which should allow such molecules to 
interact effectively with various biological targets, including membranes and 
(hydrophobic parts of) proteins. Here, the relevant physical property is surface 
activity, and the key quantifier is the critical micelle concentration (CMC), which has 
been determined using surface tensiometry [35]. A representative example of such a 
CMC determination is shown in Fig. 3, and the CMC values measured for the new 
compounds are summarized in Table 1. To the best of our knowledge, these are the 
first CMC values reported for seleninic acid (head) based amphiphiles. Indeed, 
compounds 2–4 form micelles with CMC values (2 mM for 2, 1.2 mM for 3, 1.1 mM 
for 4) similar to the one obtained for SDS under the same conditions (0.9 mM, which 
is close to its well-known literature value, i.e. 0.8 mM at 25 °C). These values are also 
in the range of the CMC values reported by us recently for selenium- and 
tellurium-based surfactants bearing a sulfate head group [18]. Not surprisingly, the 
CMC values of 2, 3 and 4 decrease with increasing hydrocarbon-chain (‘tail’) length, 
although this decrease is small and within the experimental error of the surface 
tension method employed. While 5, the most hydrophobic compound with the longest 
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‘tail’, was not soluble enough in aqueous solution to produce micelles, 1 was too 
hydrophilic and did not self-assemble at concentrations up to 10 mM under the 
experimental conditions used. 
 
Fig 3. Determination of surface activity and micellation behaviour of compounds 
1–4 using SDS as positive control. CMC values are summarized in Table 1. 
Compound n Yield (%) CMC (mM) lysis (%) of RBCs at 100 µM IC50 (µM) S. cerevisiae 
SDS - - 0.9 9.5±1.3 > 1000 
PSA - - - 2.83±1.4 > 1000 
1 6 54 - 9.6±0.2 > 1000 
2 8 55 2.0 33.9±2.8 147.9±7.6 
3 10 53 1.2 74.5±2.2 281.8±8.4 
4 12 56 1.1 86.8±3.3 295.1±6.2 
5 14 57 - - - 
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Table 1. Summary of the amphiphilic seleninic acids synthesized, their 
hydrophobic tail lengths n (see Fig. 1), synthetic yields, CMC, activity against 
RBCs and the model fungus S. cerevisiae. See text for more details 
After identifying compounds 2, 3 and 4 as the most promising candidates for further 
investigation, their ability to interact with cellular membranes was studied in a simple 
yet highly informative haemolysis assay based on RBCs. This assay is superior to 
simple liposome-based screens as it recruits real human cells with an adequately 
complex membrane, yet also avoids the pitfalls of using normal cells, which may 
show secondary membrane effects as a result of complex (intra-)cellular signaling 
[28], [29], [31], and [36-38]. In this assay, compounds 2, 3 and 4 are able to interact 
with and ultimately damage the RBCs membranes, resulting in significant haemolysis 
(Fig. 4a and b). The latter is concentration-dependent and also reflects the 
hydrocarbon chain length - and hence the CMC values. Compound 4, with the longest 
‘tail’ and also the lowest CMC, is the most potent in this assay, haemolysing over 50% 
of RBCs at a concentration as low as 10 μM. As predictable by the CMC values, other 
compounds exhibit lower activity: Compound 2 only shows significant activity at 
concentrations of 100 μM or higher and 1, which was tested as a control, is virtually 
inactive. Similar to 1, phenyl seleninic acid, a compound without any hydrophobic tail, 
is also inactive. In contrast, SDS, used here as a benchmark anionic surfactant, only 
causes haemolysis when applied at a concentration of 1 mM. While SDS is therefore 
active at higher concentrations (above its CMC), it is considerably (i.e. around 100 
times) less so than comparable seleninic acid compounds, such as 4. 
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Fig 4. Interactions of 2, 3 and 4 with the cellular membrane of RBCs. At 
higher concentrations, these compounds behave like detergents and cause 
concentration-dependent haemolysis of RBCs, as illustrated for 4 (Part a). 
Haemolysis also depends on the structure of the molecule and seems to 
increase with increasing tail length (and decreasing CMC), as shown for the 
different compounds and their reference molecules at 100 μM (Part b, please 
note that chain length refers to total number of carbon atoms in the ‘tail’ and 
hence equals n + 2; n stated in Fig. 1). At lower concentrations, membrane 
effects are more subtle and include an increase of Ca
2+
 influx into the cells, as 
measured with Fluo-4 AM as Ca
2+
 specific fluorescent stain. A23187 (A23) 
was used as positive control. (Part c) Data are depicted as mean ± SD (n = 3). 
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One way ANOVA (Dunnett) is used for statistical analysis. 
*
p < 0.05, 
**
p < 0.01 or 
***
p < 0.001. 
To investigate this effect on cell membranes further, we have employed an assay 
which monitors changes to the RBCs membrane permeability by measuring the flux 
of Ca
2+
 ions. As expected, compounds able to seriously disrupt the RBCs membranes 
at higher concentrations are also able to interfere more subtly with membrane 
processes when used in lower concentrations. At a concentration of just 3 μM, 4 
causes a significant influx of Ca
2+
 ions into the cell, whilst phenyl seleninic acid, 2 
and SDS are virtually inactive under those conditions (Fig. 4c). 
2.3.4.3. Activity against S. cervisiae 
After a brief investigation of the interactions of such compounds with the cell 
membrane of RBCs, a whole cell system has been used to study effects on a more 
complex cellular organism. These results obtained with the model organism S. 
cerevisiae, albeit clearly of a preliminary nature and limited to just one strain, indicate 
that compounds 2, 3 and 4 are rather active against this fungus at concentrations from 
100 μM onwards, i.e. at similar concentrations compared to the RBCs assay ( Fig. 5). 
As shown in Fig. 5 for compounds at a concentration of 300 μM, the activity of 2 
under those conditions is comparable to the one of miconazole, a well-known 
fungicide used here at a concentration of 100 μM as benchmark control. In fact, the 
most active compounds show a concentration dependent activity and an IC50 value of 
around 150 μM for 2 and 300 μM for 3 and 4, respectively ( Table 1). As before, these 
findings are quite instructive, as neither phenyl seleninic acid nor SDS were active at 
these concentrations. In fact, those benchmark compounds, which either lack 
amphiphilicity or a redox centre, were inactive up to a concentration of 1 mM, 
highlighting once more the importance of a synergy between the redox active 
Result and Discussion 
 
125 
 
seleninic acid and the amphiphilic character of the molecule. As far as practical 
applications of such selenium compounds are concerned, it should be mentioned that 
the compounds discussed here were not particularly hazardous against proliferating 
human cells, such as RAW 264.7 cells, where no notable cytotoxicity was found at 
these concentrations (Jacob group, unpublished data). 
 
Fig 5. Compounds 2, 3 and 4 inhibit viability of S. cerevisiae after 10 h 
incubation at 300 μM. While phenyl seleninic acid (PSA), 1 and SDS are not 
active at a concentration of 300 μM, 2, 3 and 4 are fairly active at this 
concentration. Compound 2 appears to be the most active compound in this assay 
with pronounced activity, killing almost 70% of fungal cells when employed at 
this concentration. The well-known antifungal agent miconazole (100 μM) is used 
as reference. Data are depicted as mean ± SD. One way ANOVA (Dunnett) is 
used for statistical analysis. 
*
p < 0.05, 
**
p < 0.01 or 
***
p < 0.001. 
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2.3.5. Discussion 
Taken together, our results confirm that it is fairly straight forward to synthesize 
amphiphilic seleninic acids with biological activities superior to the ones observed for 
simple seleninic acids or redox inactive surfactants. Here, the sequence of different 
synthetic steps needs to be planned and executed carefully in order to avoid the 
reaction of the seleninic acid with other functional groups in the molecule or reagents 
used (e.g. thiols). This potential problem is addressed by generating the seleninic acid 
in the final step of the synthesis. At the same time, structural diversity is achieved by 
introducing an acid chloride/amine coupling step which provides considerable 
flexibility as far as the structure and properties of the hydrophobic tail are concerned. 
Ultimately, the synthetic avenue we have mapped out means that the chemical 
synthesis of such seleninic acids is now comparably simple (with good yields of 
around 55%), yet also sufficiently flexible to construct a range of different seleninic 
acid-containing (amphiphilic) compounds. It is now possible, for instance, to 
synthesize different derivatives of our lead structures, and also to consider other 
coupling methods, e.g. involving hydroxyl instead of amine groups, as the resulting 
esters may possess pro-drug properties. 
As the hydrophilicity of seleninic acids is comparable to the one of sulfinic acids, we 
have anticipated that some of the compounds synthesized are fairly soluble in aqueous 
media and also self-assemble. Indeed, we have found that seleninic acids with 
sufficiently long hydrocarbon tails are surface active, and compounds 2, 3 and 4 with 
hydrocarbon-chains of 10, 12 and 14 carbon atoms (n + 2 according to Fig. 1) possess 
amphiphilic properties comparable to the one of SDS. Not surprisingly, compounds 
with shorter ‘tails’ are fairly soluble in water and hence do not self-assemble under 
these conditions (e.g. compound 1), whilst compounds with longer ‘tails’ (e.g. 
compound 5) are not soluble enough. Whilst 2, 3 and 4 form micelles in clean 
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aqueous solutions, micellation itself is probably of minor importance in a more 
complex biological fluid, where micellation will be disrupted by the presence of salts, 
small molecules and larger biomolecules. Here, other interactions, such as the ones 
with the lipids and proteins of cellular membranes and (hydrophobic parts of) proteins, 
will probably dominate. 
The results of the haemolysis assay support our idea of synergy, i.e. that seleninic 
acids are highly active biologically yet their simple chemical reactivity is not 
sufficient (as seen in the case of phenyl seleninic acid) and activity can be enhanced 
significantly by combining this reactivity with amphiphilicity (which on its own is 
also not sufficient, see SDS). In any case, the amphiphilic character of these 
compounds represents a considerable advantage, also in the context of 
pharmacokinetics (hydrophilic–lipophilic balance) and as far as interactions with cell 
membranes are concerned. 
Indeed, 2, 3 and 4 interact strongly with the membrane of RCBs, where they seem to 
interfere with specific membrane processes, such as Ca
2+
 influx, when used at lower 
concentrations, and cause a severe disruption of membrane integrity resulting in 
haemolysis when used at higher concentrations. The influx of Ca
2+
 ions into RBCs, 
and its role(s) in subsequent intracellular processes, is clearly an important aspect, as 
many cellular processes are Ca
2+
 dependent (including the phospholipid scramblase, a 
key enzyme in RBCs). These processes need to be studied in more detail as part of 
future studies, for instance by analyzing – changes to – the distribution of 
phosphatidylserine within the cell membrane. Compound 4, the most active among 
the new compounds synthesized, shows such subtle effects at a concentration of just 
3 μM, while haemolysis sets in at around 10 μM. Nonetheless, these interactions with 
the cell membrane are not solely due to the amphiphilic character of such molecules. 
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Compared to 4, the benchmark surfactant SDS was considerably less active, with 
haemolysis only pronounced at a concentration of 1 mM. 
Similarly, selenium- and tellurium-containing surfactants bearing a sulfate head group 
are considerably less active, with haemolysis only becoming pronounced at 
concentrations of around 100 μM [18]. Here, one should note that such 
aryl-alkyl-selenides and tellurides are redox active, for instance as catalytic 
peroxidase mimics or radical generating sites, but cannot attach covalently to proteins 
and enzymes. The ability to form covalent selenium-sulfur or selenium-selenium 
bonds with cysteine and selenocysteine residues, respectively, is exclusive to the 
compounds reported here. This special reactivity may also contribute to the biological 
activity observed in this study. 
Indeed, the presence of the seleninic acid warhead obviously contributes significantly 
to the activity of compounds such as 4. In fact, there seems to be a clear synergy 
between the seleninic acid-based redox centre and the overall amphiphilic nature of 
such compounds. Indeed, phenyl seleninic acid and SDS both are dramatically less 
active compared to 4 in the assays used as part of this study. Furthermore, many 
selenium-containing compounds have been tested by us and others in the past in 
similar assays, and the biological activities observed, such as antimicrobial activity, 
were usually only found when such compounds were used in the higher micromolar 
or low millimolar range [39-42]. 
Ultimately, it will be necessary to study the reasons behind the pronounced activity of 
such amphiphilic seleninic acids in more detail by employing a vast array of 
‘intracellular diagnostics’ tools and cell-based assays. As an educated guess, it is 
possible that such molecules readily penetrate the cell membrane and hence enter the 
cell more efficiently compared to a simple seleninic acid or other selenium 
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compounds, even amphiphilic ones. It is also feasible that such agents become 
enriched in certain parts of the cell (e.g. at membranes, certain organelles), cluster 
together there and hence exhibit a concerted, cooperative chemical reactivity. Indeed, 
it is highly likely that such molecules become integrated into membranes and also 
attach to proteins. Then again, redox activity may also be important. It is known that 
seleninic acids react fast and effectively, yet also highly selectively with thiol groups 
present in most proteins. Ultimately, proteins particularly rich in (redox sensitive) 
cysteine residues may therefore form a prime target for such molecules. Such proteins 
would be particularly badly affected, though, as they would not only undergo 
widespread cysteine modifications but also structural damage caused by hydrophobic 
interactions and partial unfolding. The latter may even enhance covalent attacks 
further by laying bare some of the cysteine residues hidden within the normal 
structure. In comparison, small molecules, such as a simple phenyl seleninic acid, 
initially may have less dramatic effects on the protein structure and enzyme activity. 
2.3.6. Conclusions 
Our studies have confirmed that amphiphilic compounds based on a seleninic acid can 
be devised and synthesized with comparable ease. Such structures not only exhibit 
interesting physico-chemical properties but also show biological activities which 
exceed the ones associated with simple selenium compounds and surfactants. Such 
seleninic acids form a new class of interesting biologically active selenium agents 
which may hit their target cells in several ways, including a pronounced chemical 
reactivity against thiol groups, redox catalysis and specific, disruptive and unfolding 
interactions with selected proteins and membranes. A seleninic acid also compares 
favourably with its two other chalcogen-analogues: whilst sulfinic acids are usually 
unreactive, ‘tellurinic acids’ are chemically extraordinarily unstable. 
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In the future, the spectrum of possible applications for such amphiphilic redox 
modulators needs to be studied in more detail, with a focus on certain mammalian 
cells (e.g. cancer cells, macrophages), bacteria (e.g. biofilms), pathogenic fungi and 
also agricultural pests [36]. Simultaneously, pharmacological and pharmacokinetic 
properties of such compounds need to be considered, whereby the latter should be 
generally favourable due to their specific design. Ultimately, amphiphilic compounds 
such as 2, 3 and 4 represent interesting new lead structures for the design and 
development of potential anticancer and antimicrobial agents. 
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3. Conclusion and outlook 
The present work has focused on the development of new amphiphilic selenium or 
tellurium containing compounds as potential anti-cancer drug candidates. The specific 
design of these compounds allowed them to kill cells by amphiphilic interactions 
(with membranes) and by breaking the redox haemostasis in cancer cells. The 
amphiphilic derivatives of sulfuric acid were successfully synthesized and purified. 
Then the membrane interactions of these compounds were analyzed with RBCs, 
nematodes and S. cerevisiae. The preliminary results proved that these selenium and 
tellurium-containing compounds can penetrate the cell membrane without destroying 
the structure of the cell membrane. Ultimately, the activities of these compounds as 
redox modulators were analyzed in HCT 116 cancer cells. The experimental results 
demonstrated that these compounds assert their anti-cancer effects by inducing cell 
apoptosis as a result of modulating the redox balance, for instance, by inducing ROS 
generation. 
Based on the chemical considerations, as motioned above (see chapter 1.6 for 
chemical considerations), the new amphiphilic selenium or tellurium containing 
sulphuric acid derivatives DP31-DP35 and DP41-DP45 (chemical structure as shown 
in chapter 2.1 in Publication 1) were synthesized successfully via fairly 
straightforward synthesis procedures, and good yields (up to 63%) were achieved  
even without further optimization. 
All the compounds present excellent solubility in aqueous medium due to their 
amphiphilic properties. Subsequently, these selenium and tellurium containing 
sulfuric acids show excellent interactions with RBCs cell membrane and reduce the 
viability of Steinernema feltiae, RAW 264.7 macrophage cells as well as HCT116 
cancer cells in a dose dependent manner. The tellurium containing sulphuric acids are 
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more potent than their selenium containing analogous. Although these compounds 
cause the haemolysis of RBCs in very high concentrations (several hundred 
micromolar), these compounds at their respective IC50 concentrations did not cause 
significant haemolysis, but strongly reduced the viability of RAW 264.7 macrophage 
cells and HCT116 cancer cells. These results indicate that the tellurium compounds 
can penetrate the cell membrane and perform their biological activity in the cytosol 
instead of simply interacting with the cell membrane. This conclusion is further 
confirmed with the EDX analysis.  
The tellurium compound DP41 can induce rapid ROS production (usually within two 
hours) on HCT116 cancer cells, while the selenium analogue DP31 has no effect on 
the ROS production. The ROS induced by DP41 triggers further ER stress as is 
confirmed by the phosphorylation of eIF2α and the expression of ATF4 and CHOP. 
The DP41-induced ER-stress subsequently induces an intrinsic apoptosis pathway, 
which is confirmed by the loss of the mitochondrial membrane potential, the release 
of cytochrome c, decreased expression of Bcl-2, the cleavage of PARP and the 
activation of caspase3. Interestingly, the tellurium compound DP41 does not induce 
the ROS production in a normal epithelial cell line (ARPE-19). Furthermore, DP41 
can disrupt the tubulin network in HCT116 cancer cells that leads to cell cycle arrest. 
Future research has to explore the various effects of the ROS production on the 
tubulin network and cell cycle arrest. 
As the other part of this thesis, several amphiphilic seleninic acid derivatives were 
designed based on the same rationale. Five amphiphilic seleninic acid derivatives 
were synthesized successfully (chemical structure as shown in chapter 2.3 in 
Publication 3). In these compounds, the seleninic acid moiety provides two functions: 
the hydrophilicity to increase the solubility and the catalytic redox activity regards for 
activity in and against cells. These amphiphilic seleninic acid derivatives were 
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investigated with RBCs and S. cervisiae. Interestingly, the amphiphilic compounds 2 
to 4 (chemical structure as shown in publication 3) demonstrated significant 
biological effects on RBCs and S. cervisiae in contrast to the nonamphiphilic 
compound 1, which implies that the amphiphilicity is a necessary requirement for the 
biological activity of this kind of compounds. At the same time, these seleninic acids 
(compounds 2 to 4) should also cause an even stronger ROS production in cancer 
cells, which may induce apoptosis at even lower concentrations of compounds used. 
Therefore, future studies should be focused on the biological behaviour of compounds 
such as 2 to 4 and on their possible applications in intracellular redox modulation of 
cells associated with diseases like scleroderma, certain types of cancer and serious 
infections and inflammatory diseases. 
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4. Summary 
The present PhD thesis describes the development of new organic selenium and 
tellurium containing compounds as synthetic redox-modulating surfactants and their 
biological activities. 
Ten organic selenide and telluride compounds (in publication 1) were designed, 
successfully synthesized and chemically characterized. These compounds are 
amphiphilic. The tellurides, in contrast to their selenide analogous, are more effective 
against not only RAW 264.7 macrophages, S. feltiae and E. coli but also against 
HCT116 cancer cells. The tellurides can modulate the intracellular redox balance by 
generating the superoxide anion radicals, which trigger the intrinsic apoptotic 
pathway.  
Further tests (in publication 2) show that the selenide compound DP31 has no effect 
on either HCT116 cancer cells or ARPE-19 cells, while the telluride analog DP41 
induces the activation of the PERK/eIF2α/ATF4 signaling pathway by modulating 
ROS, which triggers the intrinsic apoptotic pathway in HCT116 cancer cells, but not 
in ARPE-19 cells. 
Based on the success of tellurium compounds such as DP41, a series of surfactants 
containing seleninic acid head groups has been designed, synthesized, purified and 
characterized chemically (in publication 3). These compounds form micelles and 
interact strongly with the cell membrane of RBCs. Hence they promote Ca
2+
 influx, 
which induces eryptosis. Furthermore, the series of these surfactants with CMC 
properties also shows anti-funginal activity against S. cerevisiae. 
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5. Zusammenfassung 
Diese Dissertation beschreibt die Entwicklung der neuen organischen Selen- und 
Tellur-Verbindungen als Redox modulierende Tensiden und ihre biologischen 
Aktivitäten. 
Zehn organische Selenid- und Tellurid-Verbindungen (in der Veröffentlichung 1) 
wurden erfolgreich synthetisiert und chemisch charakterisiert. Sie sind amphiphil. Die 
Telluriden, im Gegensatz zu den analogen Seleniden, sind nicht nur wirksamer gegen 
RAW 264.7 Makrophagen, S. feltiae und E. coli sondern auch gegen HCT116 
Krebszellen. Diese Telluriden können das Redoxgleichgewicht durch die Erzeugung 
von Superoxid Radikalen so modulieren, dass der intrinsische apoptose ausgelöst 
wird. 
Weitere Experimente sind in der Veröffentlichung 2 zusammengefasst. Die Selenid 
DP31 zeigt keinen Effekt auf HCT116 Krebszellen oder ARPE-19 Zellen. Hingegen 
aktiviert das analoge Tellurid, DP41, die Signalweg von PERK/eIF2α/ATF4 durch 
Generierung von ROS, wodurch die intrinsische Apoptose in HCT116 Krebszellen 
ausgelöst wird. Dies geschieht aber nicht in ARPE-19 Zellen. 
Basierend auf dem Erfolg der Telluriden, wie beispielsweise DP41, wurde eine Reihe 
von Seleninsäure-enthaltender Tenside synthetisiert und chemisch charakterisiert (in 
der Veröffentlichung 3). Sie formen Mizellen, interagieren stark mit der Zellmembran 
von Erythrozyten und fördern den Ca
2+
 Einstrom. Dies induziert wiederum Eryptose. 
Interessanterweise zeigen diese Seleninsäure-enthaltenden Tenside mit amphiphiler 
Eigenschaft auch fungizide Aktivität gegen S. cerevisiae. 
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6. Abbreviation list 
ATF4 activating transcription factor 4 
ATF6 transcription factor 6 
ATP adenosine triphosphate 
Bax Bcl-2-associated X protein 
Bcl-2 B-cell lymphoma 2 protein 
BiP immunoglobulin protein  
CAT Catalase 
CD circular dichroism measurement  
CHOP C/EBP homologous protein 
CMC critical micelle concentration 
DAPI 4,6-diamidino-2-phenylindole 
DHE dihydroethidium 
DNA desoxyribonuclein acid 
EDX energy-dispersive X-ray spectroscopy 
eIF2α eukaryotic initiation factor 2α  
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eq. equivalent 
ER endoplasmic reticulum 
et al. et alii 
FACS fluorescence-activated cell sorting 
5-FU 5-fluorouracil 
G0 quiescent  
G1 Gap 1 
G2 Gap 2  
GPx glutathione peroxidase 
GR glutathione reductase 
GSH glutathione 
GSSG glutathione disulfide 
H2O2 hydrogen peroxide 
Hb hemoglobin 
HO-1 heme oxygenase 1 
IC50 half maximal inhibitory concentration 
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IRE1α inositol-requiring enzyme 1α  
Keap1 kelch like-ECH-associated protein 1 
MS mass spectrometry 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide 
NADPH nicotinamide adenine dinucleotide phosphate 
NMR nuclear magnetic resonance 
Nrf2 nuclear factor (erythroid-derived 2)-like 2 
OS oxidative stress 
PARP poly-ADP-ribose polymerase 
PC, phosphatidylcholine  
PE phosphatidylethanolamine  
PERK protein kinase RNA-like endoplasmic reticulum kinase  
P-SH protein-SH 
P-S-S-P protein-S-S-protein 
Prx peroxiredoxin  
PS phosphatidylserine  
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RBC red blood cell 
REM Reflection electron microscope 
Rf retention factor 
RNOS reactive nitrogen oxygen species  
RNS reactive nitrogen species  
ROS reactive oxygen species  
S phase synthesis period (in cell cycle) 
SD standard deviation 
SDS sodium dodecylsulfate 
Se selenium  
SOD superoxide dismutase  
Sph sphingomyeline 
Te tellurium  
UPR unfolded protein response  
UV/VIS ultraviolet/ visible 
δ chemical shift 
